US20110020920A1 - Microfabricated integrated dna analysis system - Google Patents
Microfabricated integrated dna analysis system Download PDFInfo
- Publication number
- US20110020920A1 US20110020920A1 US12/844,544 US84454410A US2011020920A1 US 20110020920 A1 US20110020920 A1 US 20110020920A1 US 84454410 A US84454410 A US 84454410A US 2011020920 A1 US2011020920 A1 US 2011020920A1
- Authority
- US
- United States
- Prior art keywords
- thermal cycling
- chamber
- microsphere
- sequencing
- microreactor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/34—Measuring or testing with condition measuring or sensing means, e.g. colony counters
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/50273—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502753—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/10—Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
- B01L2200/143—Quality control, feedback systems
- B01L2200/147—Employing temperature sensors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0803—Disc shape
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/087—Multiple sequential chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0874—Three dimensional network
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0887—Laminated structure
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/18—Means for temperature control
- B01L2300/1805—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks
- B01L2300/1827—Conductive heating, heat from thermostatted solids is conducted to receptacles, e.g. heating plates, blocks using resistive heater
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0421—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic electrophoretic flow
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/06—Valves, specific forms thereof
- B01L2400/0633—Valves, specific forms thereof with moving parts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L7/00—Heating or cooling apparatus; Heat insulating devices
- B01L7/52—Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/60—Detection means characterised by use of a special device
- C12Q2565/629—Detection means characterised by use of a special device being a microfluidic device
Definitions
- the present invention relates to microfabricated and microfluidic structures.
- the present invention relates to a microfabricated system and method for genome sequencing.
- the genome of an organism is defined by the DNA (deoxyribonucleic acid) or, for some viruses, the RNA (ribonucleic acid) of the organism. Genome sequencing is figuring out the order of the nucleotides, or bases, of a DNA or RNA strand.
- FIG. 1 A current approach to genome-scale sequencing of DNA is shown in FIG. 1 .
- This shotgun sequencing approach 100 uses bacterial transformation, selection and growth to manipulate individual genomic DNA fragments.
- the first three steps of this approach, shearing, vector ligation, and transformation (steps 102 , 104 , and 106 ), need only be performed once. As such, they do not present any particular problems.
- the last step, the capillary electrophoresis (CE) (step 114 ), has been miniaturized through microfabrication. This has reduced the cost and processing time associated with this step.
- steps 112 perform clone isolation and insert amplification.
- the amplification may be bacterial, PCR (polymerase chain reaction) or RCA (rolling circle amplification).
- PCR polymerase chain reaction
- RCA rolling circle amplification
- the invention features a microfabricated structure including a distribution channel to distribute microreactor elements carrying multiple copies of a clonal sequencing template into a plurality of thermal cycling chambers. Only one microreactor element is passed into one thermal cycling chamber wherein thermal cycling extension fragments are produced from a microreactor element.
- Purification chambers are connected to the thermal cycling chambers to capture and concentrate the extension fragments.
- Component separation channels are connected to the purification chambers to analyze the extension fragments.
- the microreactor includes a microcarrier element that carries the multiple copies of the clonal sequencing template.
- the microreactor element is a bolus or microemulsion droplet.
- the microreactor element includes a microsphere carrying the multiple copies of the clonal sequencing template.
- the sequencing template is a DNA or RNA sequencing template.
- the invention is directed to a system for performing sequencing.
- the system includes a means for shearing DNA or RNA into fragments and means for ligating the fragments to form a mixture of desired circular and contaminating linear products.
- the system further includes means for selectively removing the contaminating linear products and means for generating microreactor elements carrying multiple clonal copies of a single sequencing template.
- the system also includes means for selecting which microreactor elements have a sequencing template and microfluidic distribution means for distributing a selected microreactor element with a sequencing template into a thermal cycling chamber.
- the system includes means for ensuring that only one microreactor element will flow into one thermal cycling chamber and extension means, including the thermal cycling chambers, for producing thermal cycling extension fragments from the microreactor elements carrying multiple copies of the sequencing template.
- Purification chamber means for capturing, purifying and concentrating the extension fragments, and component separation means for analyzing the extension fragments are also part of the system.
- the microreactor element includes a microcarrier element that carries the multiple copies of the clonal sequencing template.
- the microreactor element is a bolus or a microemulsion droplet.
- the microreactor element includes a microsphere carrying the multiple copies of the sequencing template.
- the invention features a microfabricated structure including a distribution channel to distribute microspheres carrying multiple copies of a clonal sequencing template into a plurality of thermal cycling chambers.
- An autovalve is located at an exit port of a thermal cycling chamber to ensure that only one microsphere will flow into one thermal cycling chamber wherein thermal cycling extension fragments are produced from the microsphere.
- Purification chambers are connected to the thermal cycling chambers to capture and concentrate the extension fragments.
- Component separation channels are connected to the purification chambers to analyze the extension fragments.
- the diameter of a microsphere is between about 1 and 100 microns.
- the diameter of a microsphere is about 10 microns.
- Each thermal cycling chamber is in fluid communication with a separation channel.
- the sequencing template is a DNA or RNA sequencing template.
- the invention is directed to a microfabricated structure including a microfluidic distribution channel means for distributing a microsphere carrying a sequencing template into a thermal cycling chamber. Autovalving means are used to ensure that only one microsphere will flow into one thermal cycling chamber. Extension means, including the thermal cycling chamber, produce thermal cycling extension fragments from a microsphere carrying a sequencing template. Integrated purification chamber means are used for capturing, purifying and concentrating the extension fragments. Component separation means are used to analyze the extension fragments.
- the extension means is a Sanger extension means including a plurality of thermal cycling chambers.
- the autovalving means includes an autovalve at an exit port of the thermal cycling chambers.
- Purification chamber means includes purification chambers connected to the thermal cycling chambers.
- the component separation means is a capillary array electrophoresis means including a plurality of microchannels connected to the purification chambers.
- the sequencing template is a DNA or RNA sequencing template.
- the invention is directed to a microfabricated apparatus including a thermal cycling chamber.
- the thermal cycling chamber is configured to receive a microsphere carrying a clonal template.
- the chamber has an inlet port and an outlet port wherein the outlet port includes a constriction that is configured to trap a microsphere in the chamber and to substantially block further flow into the thermal cycling chamber.
- the shape of the constriction is substantially circular or semicircular.
- a first value is located in an inlet channel in fluid communication with the inlet port and a second valve is located in an outlet channel in fluid communication with the outlet port. In operation, the second valve is closed before the first valve to move a microsphere out of the constriction and into a main body portion of the chamber before thermal cycling.
- a purification chamber is in fluid communication with the outlet port of the thermal cycling chamber and an outlet port of the purification chamber is in fluid communication with a component separation apparatus.
- the invention features a system for performing sequencing.
- the system includes means for shearing DNA or RNA into fragments and means for ligating the fragments to form a mixture of desired circular and contaminating linear products.
- the system further includes means for selectively removing the contaminating linear products and means for generating microspheres carrying multiple clonal copies of a single sequencing template.
- the system also includes means for selecting which microspheres have a sequencing template and microfluidic distribution channel means for distributing a selected microsphere with a sequencing template into a thermal cycling chamber. Additionally, the system includes means for ensuring that statistically only one microsphere will flow into one thermal cycling chamber.
- the system also includes extension means, including the thermal cycling chambers, for producing thermal cycling extension fragments from the microspheres carrying multiple copies of the sequencing template.
- extension means including the thermal cycling chambers, for producing thermal cycling extension fragments from the microspheres carrying multiple copies of the sequencing template.
- Purification chamber means for capturing, purifying and concentrating the extension fragments, and component separation means for analyzing the extension fragments are also part of the system.
- the ensuring means is at least one of an autovalve in the thermal cycling chamber, an optical detector, and a timing mechanism.
- the optical detector is an optical scanner that detects light scattered from a microsphere.
- the timing mechanism includes a pneumatic input located adjacent to an inlet of a thermal cycling chamber.
- the invention features a system for performing DNA sequencing.
- the system includes means for shearing DNA into DNA fragments and means for ligating the DNA fragments to form a mixture of desired circular and contaminating linear products.
- the system also includes means for exonuclease degredation for selectively removing the contaminating linear products and emulsion PCR reaction means for generating microspheres carrying multiple clonal copies of a single DNA sequencing template.
- the system includes fluorescent activated cell sorting (FACS) means for selecting which microspheres have a DNA sequencing template.
- FACS fluorescent activated cell sorting
- Microfluidic distribution channel means are used to distribute a selected microsphere with a DNA sequencing template into a thermal cycling chamber.
- Autovalving means are used to ensure that statistically only one microsphere will flow into one thermal cycling chamber.
- Sanger extension means including the thermal cycling chambers, are used to produce thermal cycling extension fragments from the microspheres carrying multiple copies of the DNA sequencing template.
- Integrated purification chamber means are used to capture, purify and concentrate the extension fragments, and capillary array electrophoresis means are used to analyze the extension fragments.
- the microreactor element includes a microcarrier element which carries the multiple copies of the clonal sequencing template.
- the microreactor element is a bolus or a microemulsion droplet.
- the microreactor element includes a microsphere carrying the multiple copies of the clonal sequencing template.
- the distributing step is done such that only one microreactor element will pass into one thermal cycling chamber. An autovalve is used at an exit port of the thermal cycling chambers to ensure that only one microreactor element will flow into one thermal cycling chamber.
- the generating step includes generating multiple clonal copies of a sequencing template by emulsion PCR reactions or by a flow through PCR process.
- the selecting step is FACS.
- the capturing step uses an oligonucleotide capture matrix.
- the invention features a method for sequencing.
- the method includes receiving a microsphere carrying a clonal template at an inlet port of a thermal cycling chamber and using a constriction at an outlet port of the chamber to trap the microsphere in the chamber and substantially block further flow into the chamber.
- a first valve is located at an inlet port of the thermal cycling chamber and a second valve is located at an outlet port of the thermal cycling chamber such that the second valve may be closed before the first valve. As such, a microsphere is moved out of the constriction and into a main body portion of the thermal cycling chamber before thermal cycling.
- FIG. 2 is a diagrammatic representation of the steps involved in a genome sequencing process in accordance with the present invention.
- FIG. 3 is a diagrammatic representation of a cloning process that may be used with the present invention.
- FIG. 4A is a diagrammatic representation of a single-channel microdevice in accordance with the present invention
- FIG. 4B is an enlarged view of a portion of the device of FIG. 4A
- FIG. 4C is a diagrammatic exploded view of the single-channel microdevice.
- FIG. 6A is a diagrammatic representation of a sequencing reaction chamber of a device in accordance with the present invention, including an enlarged view of a portion of the reaction chamber;
- FIG. 6B is a view along line 6 B- 6 B of FIG. 6A ;
- FIG. 6C is a diagrammatic representation of a constriction region of the reaction chamber of FIG. 6A that is used to trap beads carrying the DNA to be sequenced.
- FIG. 7A is a bright field image of a constriction region of an empty sequencing reaction chamber
- FIG. 7B is a bright field image of a constriction region of a sequencing reaction chamber filled with solution but with no microsphere at the constriction region
- FIG. 7C is a dark field image of a microsphere located at a constriction region of a sequencing reaction chamber.
- FIG. 8A is a diagrammatic representation of an alternate embodiment of a constriction region of a sequencing reaction chamber designed for bead capture
- FIG. 8B is a view along line 8 B- 8 B of FIG. 8A .
- FIG. 9A is a diagrammatic representation of one quadrant of an integrated sequencing array system
- FIG. 9B is an enlarged view of a portion of the system of FIG. 9A .
- FIG. 10A is a diagrammatic representation of a continuous flow through PCR microfabricated device
- FIG. 10B is an enlarged view at lines 10 B- 10 B of FIG. 10A , illustrating a “T”-injector region of the microfabricated device
- FIG. 10C is an enlarged view at lines 10 C- 10 C of FIG. 10A , illustrating a portion of the channels of the microfabricated device.
- microreactor elements such as a microemulsion droplet or a bolus which, in some embodiments, include a microcarrier element such as a microsphere or bead.
- the microcarrier element contained within a bolus or a microemulsion droplet, is useful in capturing DNA or RNA products; that is, amplified DNA or RNA can be chemically linked to the microcarrier element.
- the amplified DNA or RNA may be carried by a microreactor element without the use of a microcarrier element.
- a PCR reaction may be done in a bolus or a microemulsion droplet, and then the resulting bolui or microemulsion droplets may be routed to the next step of the process.
- a microfabricated integrated DNA analysis system (MINDS) of the present invention provides a system and method that are readily compatible with microfluidic sample component separation devices.
- the MINDS process 200 begins with the shearing of DNA into DNA fragments (step 202 ).
- the fragments are then ligated to form a mixture of desired circular and contaminating linear products (step 204 ).
- the contaminating linear products are then selectively removed, for instance, by exonuclease degradation (step 206 ).
- a colony of microspheres carrying multiple clonal copies of a DNA sequencing template is next formed (step 208 ).
- the colony may be generated, for example, by emulsion PCR reactions.
- the microspheres having a DNA sequencing template are then identified (step 210 ).
- the microspheres may be identified by a fluorescence activated cell sorting (FACS) technique. Only one such run is required, and it may take 6 hours or less to complete.
- FACS fluorescence activated cell sorting
- the microspheres with the DNA sequencing templates are then distributed into thermal cycling or sequencing reaction chambers where extension fragments are produced; thereafter, the fragments are purified and concentrated (step 212 ).
- the extension fragment are then analyzed by a sample component separation apparatus, for example, a CE device (step 214 ).
- the present invention eliminates the laborious, expensive, and time consuming in vivo cloning, selection, colony isolation, and amplification steps of conventional sequencing. Instead, these steps are replaced with readily miniaturized and automated in vitro steps.
- FIG. 3 provides an overview of a cloning process 300 that may be used with the MINDS.
- the process includes library creation and selection.
- genomic DNA is isolated from whole blood and then sheared in a nebulizer generating DNA fragments (steps 302 and 304 ).
- the DNA fragments are then subjected to an enzymatic treatment to yield blunt-end DNA (step 306 ).
- Processed fragments are ligated into a vector yielding a mixture of desired circular and contaminating linear products (steps 308 and 310 ).
- Exonuclease degredation then selectively removes the insert and vector, the contaminating linear products, from the ligation product so that greater than about 95% of the remaining vectors contain inserts, the desired circular products (step 312 ).
- the first five steps of the cloning process 300 follow standard library creation procedures. More specifically, Invitrogen (Carlsbad, Calif.) supplies a TOPO Subcloning Kit (#K7000-01) which is capable of generating a 1 to 6 Kb insert genomic shotgun library in two hours.
- the subcloning kit requires about 20 micrograms ( ⁇ g) of genomic DNA that can be obtained from 1 mL of whole blood using Qiagen's (Oslo, Norway) Blood & Cell Culture DNA Mini Kit (#13323). The DNA is sheared in a nebulizer generating 1-6 Kb DNA fragments.
- fragments are then subjected to an enzymatic treatment with T4 DNA and Klenow polymerases and calf intestinal phosphatase (CIP) to yield dephosphorylated blunt-end DNA.
- CIP calf intestinal phosphatase
- Processed fragments are next ligated into Invitrogen's pCR 4 Blunt-TOPO vector.
- Use of covalently linked vaccinia virus topoisomerase I to the cloning vector results in rapid and efficient ligation (a 5 minute room temperature ligation yields greater than 95% transformants) and permits dephosphorylation of the inserts prior to ligation thereby preventing chimeric clone formation.
- the final step in canonical library creation (step 312 ), which has been modified to be compatible with the in vitro MINDS process, is bacterial transformation and antibiotic selection.
- Exonuclease degredation selectively removes insert and vector from the desired ligation product.
- Lambda exonuclease (New England BioLabs #M0262S) can be used for this step as it degrades 5′-phosphorylated and non-phosphorylated double-stranded DNA but is unable to initiate DNA digestion at the nicks present in the vector after ligation.
- the resulting library contains greater than 6,000 fold molecular excess needed for 10 ⁇ sequence coverage, though this excess is reduced through dilution in the single-molecule PCR amplification step described later.
- a gel separation and band purification step can be performed after DNA shearing (step 304 ) if strict control over insert size is required for paired-end whole-genome de novo sequencing.
- insert size can be restricted using limiting extension times during PCR amplification or flow cytometric selection of microspheres within a narrow fluorescence intensity range. Labeling microsphere-clones with an intercalating dye, such as thiazole orange (TO), will yield a fluorescent signal proportional to amplicon size. Since flow cytometry is a step in the MINDS process, this is an appealing size-selection method that also eliminates the >5% recircularized vectors with the only drawback being reduced yield.
- an intercalating dye such as thiazole orange (TO)
- the vector used in the subcloning kit may be optimized for sequencing with the T7 and T3 priming sites 33 bp (base pairs) away from the insertion site. Since the MINDS vector is free from biological constraints, the sequencing priming sites can be moved closer to the insert site and the pUC ori, fl ori, lacZ, and antibiotic resistance genes can be removed. Optimized acrydite capture sequences and homo-PCR priming sites can be inserted for improved sample clean-up and reduced primer-dimer formation.
- Sequencing in the MINDS process may use clonal template DNA attached to individual microspheres or beads.
- the clonal attachment is accomplished by linking one of the primers covalently to a microsphere.
- CPG Biotech (Lincoln Park, N.J.) produces a 5 micron ( ⁇ m) controlled pore glass paramagnetic microsphere with a long chain alkylamine linker for covalent attachment to an amine modified primer that can consistently bind 80 million DNA molecules.
- 30 cycles of PCR has a theoretical gain of 1 billion. In practice, the gain is lower due to less than 100% efficiency for each cycle, reduced enzyme activity in later cycles, and limiting reagents in pL scale reactions.
- a single DNA molecule and a single primer-coupled microsphere must be placed in a PCR reactor.
- Efficient single-molecule PCR requires extremely small volume reactors (1-10 pL) to increase the effective concentration of a single DNA molecule. Approximately 30 million microsphere clones are needed to sequence a human-size genome. High-throughput combination of a single microsphere and DNA molecule in a chamber is possible using statistically dilute microemulsion solutions. If the DNA molecules and microspheres are each diluted such that one species is present in 10 times the reactor volume, there is a high probability (greater than 99%) of concurrence in 1% of the reactors. Because 99% of the reactors are non-productive, 100-fold more reactions (3 billion) are required to generate 30 million microsphere clones.
- PCR devices Two possible approaches for generating large numbers of small volume reactions are microfabricated PCR devices and emulsion PCR.
- PCR devices require thousands of runs to achieve the required 3 billion reactions.
- Emulsion PCR has the ability to thermally cycle millions to billions of separate compartments in a single tube using a conventional thermal cycler.
- Clonal PCR amplicons attached to magnetic particles using emulsion PCR have been produced.
- each microsphere contained greater than 10,000 250 bp amplicons, a value below the theoretical maximum of 600,000 amplicons based on the available nucleoside triphosphates in each 5 ⁇ diameter compartment.
- Fifteen micron microemulsion PCR compartments have been demonstrated in which the maximum number of 1,000 bp amplicons is 5 million—a value ten times less than the minimum required 50 million initial template copies. This problem may be solved in a variety of ways:
- additional microemulsion PCR steps could be performed to increase the amount of DNA linked to the beads.
- an additional non-reagent-limited amplification step may be necessary after the fluorescence flow cytometry step.
- Secondary PCR amplification can be performed in an on-chip, dual-use thermal cycling chamber in which paramagnetic microspheres are routed to individual reactors and magnetically retained. Fresh PCR mix is passed into the chambers and thermal cycled 15 ⁇ to saturate each microsphere to the maximum of 80 million templates. In this case, the magnetic field is maintained as Sanger-sequencing reaction mix is washed into the chambers followed by solid-phase sequencing. Finally, the S/N of the scanner may be improved up to 10-fold enabling sequencing of about a 10-fold lower template than calculated above.
- Approximately 15 million 15 ⁇ m diameter compartments may be created in a 25 ⁇ L aqueous phase, 75 ⁇ L oil phase emulsion. Three billion compartments are required to generate 30 million coincident single DNA molecule and microsphere events. Thus, approximately two 100 ⁇ L 96-well plate reactions are required. When the reactions are complete, 30 million microsphere clones must be separated from a background of 300 million un-labeled microspheres.
- the beads having sequencing templates may be identified by FACS.
- a system that may be used is the BD FACS ArrayBioanalyzer System, available from BD Biosciences, San Jose, Calif.
- the BD FACSArray flow cytometer can process up to 15,000 events per second, enabling the isolation of all clones needed for 10 ⁇ coverage of a 3 billion base genome in less than 6 hours.
- the beads will be treated with an intercalation dye, such as TO, that is nonfluorescent until intercalated into double-stranded DNA.
- the fluorescence intensity of TO is linearly proportional to the amount of DNA allowing for easy differentiation between beads that have amplified DNA and those that do not.
- FIGS. 4A , 4 B, and 4 C A diagrammatic representation of a single-channel microdevice 400 in accordance with the present invention is shown in FIGS. 4A , 4 B, and 4 C.
- the device may be fabricated as a four layer glass-glass-PDMS (polydimethysiloxane)-glass sandwich that incorporates microfluidic valves, heaters, resistive temperature detectors (RTDs), and all reaction, capture and clean-up, and CE structures.
- the device in another configuration, may be fabricated as a glass-PDMS-glass-glass stack.
- a four layer microfabricated system including valves, heaters, RTDs, chambers, and CE structures is described in U.S.
- the microdevice 400 is capable of performing all down-stream steps in the MINDS process including extension fragment production, reaction clean-up, and extension fragment separation (steps 212 and 214 of FIG. 2 ).
- the device 400 includes a thermal cycling or sequencing reaction chamber 402 , a capture or purification chamber 404 , and a CE system 406 including separation channels 407 . As shown, these components of the device 400 are connected by various valves and channels.
- a heater (not shown), for example, a kapton heater, may be used to heat the contents of the thermal cycling chamber.
- the template of the chamber is monitored by RTDs 405 .
- the device 400 includes three glass layers, including a channel layer 430 , a via layer 432 , and a manifold layer 434 .
- a PDMS membrane layer 436 is provided between the via layer 432 and the manifold layer 434 .
- the top layer 430 contains the thermal cycling reactors, the capture chambers and the CE features.
- the second layer 432 incorporates the RTDs on the top surface of the glass wafer and etched features on the bottom to form the valves and pumps with the membrane layer 436 below.
- the last layer 434 includes the heater, and completes the valve and pump structures with pneumatic actuation lines and displacement chambers.
- a sequencing master mix is loaded from a port 408 of the device 400 through a microvalve 410 into the thermal cycling chamber 402 .
- the volume of the chamber 402 may be approximately 250 nano-liters (nL).
- the separation channels of the CE system 406 are filled with linear polyacrylimide from a port 412 to a port 414 .
- the CE system may be a 16-centimeter (cm) hyperturn system.
- An acrydite capture matrix is loaded from a port 416 to a port 418 to fill the capture chamber 404 and an intervening pinched chamber 419 .
- extension fragments and residual reactants are electrokinetically driven through a valve 420 and a channel 422 into the capture chamber 404 .
- the captured extension fragments are then electrophoretically washed and injected into a channel 424 for separation by the CE system 406 .
- FIGS. 5A , 5 B, and 5 C display fluorescence images (where relative applied potentials are indicated by “+” and “ ⁇ ”) from the operation of a microdevice 500 like that of the device 400 where thermal cycling, capture, wash (purification), and concentration of a sample as well as separation were performed.
- the polymerized capture matrix was then loaded into a capture chamber 504 using a 1 mL syringe.
- a polymer sequencing matrix (CEQ, Beckman Corp., Fullerton, Calif.) was loaded into a CE system 506 using a high-pressure gel loader.
- a C-track master mix was prepared containing 80 nM ET-primer, 1 ⁇ C terminator mix (Amersham), and 4 nM PCR product and injected into a 250 nL thermal cycling chamber or reactor (not shown). Thermal cycling (35 ⁇ , 94° C. 30 seconds, 45° C. 40 seconds, 70° C. 40 seconds) was performed on-chip using a LabVIEW program (National Instruments, Austin, Tex.).
- Sequencing reaction clean-up was performed by first equilibrating the microdevice on a 50° C. heated stage for 30 seconds. Then, sample capture ( FIG. 5A ) was initiated by applying 2000 V to the capture chamber outlet (port 416 of FIG. 4A ) while grounding the reactor inlet (port 408 of FIG. 4A ). Thus, the sample containing extension fragments and residual nucleotides, primers, and salts was electrophoretically driven from the thermal cycling chamber through a channel 522 into the capture chamber 504 . Extension fragments hybridize to the Acrydite matrix in the capture chamber while residual reactants pass through. When oligonucleotide capture was complete, the retained extension fragments were electrophoretically washed ( FIG.
- the denatured sample is directly injected into separation columns 507 of the CE apparatus 506 ( FIG. 5C ) by applying 2,500 V to the anode while grounding the capture chamber outlet. (Images have been processed to highlight channel structure and remove fluorescent surface contamination.)
- a straight cross-injector and a 30-cm separation capillary could be used. This will improve resolution.
- the microsphere-colony creation procedure and a single reactor microdevice can generate single-ended reads suitable for resequencing efforts.
- De novo whole-genome shotgun sequencing of complex genomes requires paired-end reads from short and long insert clones. Long-range PCR followed by fluorescent flow cytometry can be used on a subset of microspheres to selectively generate long-insert clones.
- Traditional paired-end sequencing requires procedural and microdevice modifications such that clonal DNA could be released from the microspheres and routed to separate forward and reverse sequencing reactors.
- An alternative strategy is to perform forward and reverse sequencing simultaneously on a subset of bases using an altered base labeling scheme. These paired-end reads generate long single or double-base reads suitable for anchoring four-base single-ended reads in the sequence assembly.
- a microsphere 600 is used to transfer a clonal template into a thermal cycling or sequencing reaction chamber 602 where sequencing reactions are performed. This process requires that one microsphere be introduced in each sequencing reaction chamber. Autovalving techniques for trapping an individual microsphere in a sequencing reaction chamber, without the need for individually actuated valves and sensing, are used for this purpose.
- the reaction chamber 602 includes an introduction channel or arm 604 and an exit channel or arm 606 .
- the introduction channel is in fluid communication with an inlet port 605 of the reaction chamber, while the exit channel is in fluid communication with an outlet port 607 of the reaction chamber.
- Self-valving is achieved by creating a constriction or constriction region 608 at the outlet end or port 607 of the reaction chamber.
- the constriction region is semicircular in shape.
- the constriction will trap a microsphere before it exits the chamber.
- the trapped microsphere will produce a drop in the flow rate, thereby preventing any further microspheres from flowing into the chamber.
- the dilution of the microspheres will be chosen such that the probability that another microsphere flows into the reaction chamber before the first microsphere has blocked the chamber is below about 0.5%. If this statistical approach is unreliable or leads to low sorting rates, an on-chip sensor for bead light scattering can be used, and two valves in the sorting loop can be added to produce a more temporally uniform bead distribution.
- Glass fabrication processes can be used to create the device shown in FIGS. 6A-6C .
- all features except the constriction were isotropically etched to a depth of 30 ⁇ m.
- the sample introduction and exit channels were set to 70 ⁇ m in width and 15 mm in length.
- the sequencing reaction chamber had a volume of 250 nL.
- a second mask was used to fabricate the constriction.
- a more viscous photoresist SJR 5740, Shipley, Marlborough, Mass.
- a higher viscosity photoresist gives more uniform coating on the featured wafer.
- the constriction pattern was transferred to the coated wafer using a contact printer. Alignment marks were used to align ( ⁇ 1 ⁇ m) the constriction with the already etched channels and chamber. After development, the amorphous silicon masking layer was removed via plasma etching, and the exposed glass was wet etched using 5:1 BHF with an effective etch rate of 2 ⁇ m/hour for 1.5 hours. This gave a constriction depth or height of 3 ⁇ m. The constriction width was set to 8 ⁇ m and the length was set to 15 ⁇ m.
- a device like that shown in FIGS. 6A-6C was pre-filled with a solution of 1 ⁇ Tris (pH 8.0) and 1% Triton X-100.
- the microsphere solution (6 ⁇ L) was pipetted into an inlet access hole.
- a vacuum line was used to draw the beads through the chamber.
- the pressure drop increased from ⁇ 60 kPa to ⁇ 70 kPa when a microsphere was trapped at the constriction, and blockage occurred within the first 60 seconds.
- the experiment was continued for 12 minutes and no other microsphere was observed to enter the chamber.
- FIGS. 7A and 7B show bright field images of a constriction region 708 of a thermal cycling chamber 702 at 20 ⁇ magnification when empty and with solution (but no microsphere), respectively.
- FIG. 7C shows a dark field image of the thermal cycling chamber 702 with a fluorescent microsphere 700 trapped at the constriction 708 and acting as a valve.
- the experiments were performed for microspheres of approximately 6 ⁇ m diameter. The concept is easily scalable to larger microspheres to increase the number of templates in the reactor. Also, smaller microsphere could be used.
- the microspheres in particular, may be between about 1 and 100 ⁇ m in diameter. In one embodiment, they are about 10 ⁇ m in diameter.
- FIGS. 8A and 8B An alternative autovalving embodiment, which will result in complete flow blockage, is presented in FIGS. 8A and 8B .
- a reaction chamber 802 has a near circular constriction or constriction region 808 formed at a chamber outlet port 807 .
- the chamber and the constriction will be double-etched; that is, they will be etched on both of two joined glass surfaces. This will produce a near circular constriction, as opposed to a semicircular constriction of the embodiment of FIGS. 6A-6C . This will provide better valving for trapping a microsphere 800 .
- valves will be incorporated on either side of a sequencing reaction or thermal cycling chamber 402 (see FIGS. 4A and 4B ). Once a microsphere has been trapped at the constriction, it needs to be pushed back into the chamber for thermal cycling so that there is good accessibility of the clonal templates to the polymerase, primers, dNTPs and ddNTPs.
- the valve 420 By closing the valve 420 at the outlet of the chamber before closing the inlet valve 410 , the microsphere will be pushed back into the chamber as a result of the finite dead volume of the valves. This principle is easily scaled to an array system by actuating the inlet and outlet valves in parallel.
- FIGS. 9A and 9B A schematic of such a system 900 is shown in FIGS. 9A and 9B . This system extends the single channel device of FIGS. 4A-4C to an array structure that is able to perform highly parallel analyses.
- the system 900 includes multiple thermal cycling chambers 902 and associated sample purification or capture chambers 904 arranged about a circular axis to form a radially parallel system.
- the thermal cycling chambers and the sample purification chambers are all integrated with a CE analyzer system 906 including separation channels or microchannels 908 .
- the CE analyzer has a common central anode (A) 910 , a cathode reservoir (C) 912 , and a waste reservoir (W) 914 .
- the cathode and anode reservoirs are associated with adjacent sets of separation channels 908 .
- the microchannels 908 are connected to the anode 910 for detection using a rotary confocal fluorescence scanner of the type discussed in the article entitled: “High-throughput genetic analysis using microfabricated 96-sample capillary array electrophoresis microplates”, Peter C. Simpson, et al., Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 2256-2261, March 1998, which is hereby incorporated by reference.
- the system 900 further includes a distribution channel 916 , integrated heaters 918 a and 918 b , and RTDs 920 .
- the heaters 918 a and 918 b address the thermal cycling chambers and purification chambers, respectively, in parallel. As such, the use of simple ring heaters to drive the thermal cycling and sample purification reactions is more than adequate.
- the temperature of these reactions are monitored by the RTDs.
- four-equally spaced RTDs are integrated on the substrate to provide precise temperature sensing across the heater 918 a for optimal thermal cycling performance.
- four-equally spaced RTDs may be used to monitor the temperature of the heater 918 b.
- the system 900 also includes an array of integrated valves and ports for controlling the system flow process.
- the valves may be monolithic elastomer (PDMS) membrane valves.
- PDMS monolithic elastomer
- the system may be fabricated as described in the above-identified U.S. patent application Ser. No. 10/750,533, which has been incorporated by reference. As such, the system may include a four layer glass-glass-PDMS-glass stack that incorporates the microfluidic valves and pumps, the RTDs, the thermal cycling chambers, the clean-up and concentration chambers, and the CE channels.
- the system 900 in one embodiment, includes 24 thermal cycling chambers, 24 purification chambers, and 24 CE channels arranged on a quadrant of a 150-mm diameter glass substrate.
- Each thermal cycling chamber ( ⁇ 250 nL) is isolated from the distribution channel by PDMS membrane valves (V 1 ) 922 . Rigid containment of the chamber volume with active valves is necessary for bubble-free loading and immobilization of a sample during thermal cycling since sample movement, bubble formation, and sample evaporation can seriously affect the performance.
- the RTDs may be fabricated of titanium (Ti) and platinum (Pt). Different materials (Au, Al, Pt, Ni) using different metal deposition techniques, such as sputtering and both thermal and electron-beam evaporations, may be used to fabricate the heaters. Nickel heaters exhibit good heating uniformity, have good scratch resistance, show no noticeable degradation of performance even after hundreds of thermal cycles, and are easily fabricated.
- the microfabricated heaters and the thermal cycling chambers are positioned away from the CE microchannels to avoid evaporation of buffer in the cathode reservoirs and to minimize the heating of the injection region during thermal cycling.
- the resistive ring heaters can be fabricated on the back side of the bottom wafer to ensure good thermal transfer between the heaters and the chambers.
- the equally-spaced RTDs are integrated on the microplate to provide precise temperature sensing ensuring temperature uniformity across the heaters for optimal performance.
- the thermal cycling chambers may be cycled with a LabVIEW program (National Instruments, Austin, Tex.). (LabView VI) Temperature control can be accomplished through a proportion/integration/differentiator (PID) module within the LabVIEW program.
- LabVIEW VI National Instruments, Austin, Tex.
- PID proportion/integration/differentiator
- a sequencing separation matrix is introduced into the CE separation channels using positive pressure through the anode 910 .
- a separation matrix fills the cathode reservoirs 912 and the waste reservoirs 914 , as well as arms 924 connecting the cross-injection point to the associated sample purification chambers.
- the filling rate can be modulated through adjustment of the widths and lengths of the various interconnecting channels.
- the cathode and anode reservoirs, and the connecting arms may be filled at the same rate.
- Water for example, is loaded from a loading (L) port 926 connected to the distribution channel 916 to fill the thermal cycling chambers 902 and the sample purification chambers 904 ensuring continuity for subsequent processes.
- An exit port (E) 936 is shared by both the thermal cycling chambers 902 .
- a capture gel matrix is loaded into the sample purification chambers through ports (F) 928 .
- Libraries of clonal DNA beads that have been sorted and prepared using a FACS unit are loaded from the port 926 (valves (V 1 ) 922 and (V 2 ) 930 open, and valve (V 3 ) 932 closed) using, for example, a syringe pump.
- a pressure transducer is employed in the inlet to monitor the head pressure. Auto-valves at the exit ports of the thermal cycling chambers will stop the flow into a chamber once a bead is trapped in the auto-valve as described above. As each auto-valve is filled with a bead in each thermal cycling chamber, the head pressure will continue to increase. In this manner, loading a bead in each thermal cycling chamber is achieved by monitoring the head pressure.
- valves (V 2 ) 930 and (V 1 ) 922 are closed and thermal cycling reactions initiated. Since the beads will be sorted directly in the thermal cycling cocktail, no additional steps are needed before thermal cycling. Alternatively, sorting could be performed in a buffer followed by introduction of the thermal cycling cocktail into the thermally cycling chambers to minimize reagent usage.
- the heaters 918 a and 918 b drive the thermal cycling and sample purification reactions, and the reaction temperatures are monitored by the RTDs 920 .
- Thermal cycling products are driven to the purification chambers by applying an electric field across the port (L) 926 and a sample port or electrical contact point (S) 934 with the valves (V 1 ) 922 and (V 3 ) 932 open. Flushing of the non-captured reagents is performed by applying an electric field between the port (S) 934 and the port (F) 928 . Thereafter, the sequencing products are injected from the purification chambers into the associated microchannels 908 for CE separation, by applying a potential between the port (S) 934 and the waste reservoir (W) 914 .
- the rotary confocal fluorescence scanner is used to detect the sequencing samples. The scanner interrogates the channels sequentially in each rotation of the scanner head.
- separations of the purified DNA sequencing products are achieved by using cross-injection.
- direct injection could be used.
- the microemulsion PCR approach of colony formation is replaced by a continuous flow through PCR technique in which bolui or droplets for performing single-molecule PCR amplification of templates are formed and then amplified.
- the bolui or plugs are formed, for example, by combining an aqueous solution of PCR reagents and dilute template fragments with a hydrophobic solution that acts as a carrier.
- the bolui produced by this technique will contain statistically a small number of copies of a sequencing template. Ideally the concentration is chosen so that only one in 10 bolui contain a single sequencing template. This mean that only one in 100 will simultaneously contain undesirably two templates.
- a microsphere or bead carrying one of the primers in the PCR reaction can also be entrained within a bolus or droplet in the process of performing this technique.
- a colony may comprise bolui carrying multiple clonal copies of a single sequencing template or bolui having microspheres carrying such copies.
- a continuous flow through microfabricated PCR system 1000 includes ports 1002 and 1004 .
- An aqueous solution of microspheres, PCR reagents and template fragments in one embodiment, is introduced into a “T”-injector region 1006 via the port 1002 , while a hydrophobic carrier solution is introduced into the “T”-injector region via the port 1004 .
- a bolus or droplet 1012 containing a microsphere is thus formed downstream of the “T”-injector region.
- the system 1000 further includes an optical sensor 1007 ( FIG. 10B ) located downstream of the “T”-injector near an input end of a channel 1014 .
- the sensor may comprise a focused laser beam and a photodiode to detect off-axis light scattering.
- the system 1000 is designed for two-step PCR where the anneal and extend steps are combined.
- the system includes two temperature zones 1008 and 1010 through which droplets 1012 pass via the flow through channels 1014 .
- the device 1000 includes RTDs 1016 and associated RTD contact pads 1018 for monitoring the temperature of the different temperature zones.
- the microsphere can be treated with an intercalation dye, such as TO, that is nonfluorescent until intercalated into double-stranded DNA. Therefore, the microspheres that have amplified DNA can be identified by, for example, the FACS technique after they pass through the port 1020 . Thereafter, the microspheres are introduced into a distribution channel of a device like the device 900 (See FIGS. 9A and 9B ). The microspheres that do not have amplified DNA, on the other hand, will be disposed of.
- an intercalation dye such as TO
- the continuous flow through PCR system 1000 uses nanoliter droplets of PCR reagents suspended in a perfluorohydrocarbon carrier. See, Song, H., et al., “A microfluidic system for controlling reaction networks in time”, Angewandte Chemie - International Edition 42, 768-772 (2003), which is hereby incorporated by reference. Droplets containing microspheres, PCR reagents, and template fragments, separated from one another by an immiscible liquid, are formed at the microfabricated T-injector 1006 . Thereafter, the droplets flow through the regions 1008 and 1010 of the device that are held at anneal-extend-denature temperatures.
- the lengths of the channels 1014 in the different temperature zones 1008 and 1010 are selected based on required residence times at those temperatures.
- the cross-section of the channels and the desired flow rates are chosen to achieve stable droplet formation.
- the parameters of the device may be set to achieve a hot start at the denature temperature for 90 seconds, followed by anneal/extend for 45 seconds with a 1 second auto-extend for 35 cycles and a denature time of 15 seconds.
- the last 15 cycles may be configured to have a constant anneal/extend time of 80 seconds.
- the device 1000 may comprise two 1.1-mm thick by 10-cm diameter borofloat glass wafers.
- the channels on the patterned wafer may have a D-shape cross-section with a width of about 210 ⁇ m and a depth of about 95 ⁇ m.
- Ti/Pt RTDs may be fabricated for monitoring temperature gradients at different points in the device. Holes may be drilled for accessing the channels, and the two wafers may be thermally bonded to each other to form enclosed channels.
- the nanoports 1002 and 1004 are used to interface the device with micro-liter syringes through PEEK tubing.
- the glass surface of the channels may be rendered hydrophobic through silanization with 1H,1H,2H,2H-perfluorodecyltrichlorosilane, based on a procedure published by Srinivasan et al., “Alkyltrichlorosilane-based self-assembled monolayer films for stiction reduction in silicon micromachines”, Journal of Microelectromechanical Systems 7, 252-260 (1998), which is hereby incorporated by reference.
- Two syringe pumps may be used to dispense water and a 10:1 mixture of perfluorodecalin (mixture of cis and trans, 95%, Acros Organics, New Jersey, USA) and 1H,1H,2H,2H-perfluorooctanol (Acros Organics, New Jersey, USA) at a flow rate of 0.5 ⁇ l/min each.
- FIG. 10B shows the droplet formation process at the T-injector at about 1 droplet/s
- FIG. 10C shows the droplets as they move through the channel.
- the technique uses microbeads in 10 nL droplets. Throughput is maintained at one in ten droplets containing both a single template molecule and a single bead.
- the aqueous PCR mix is prepared such that there is one template molecule per 100 nL of mix, corresponding to one molecule for every ten droplets.
- microbeads at a concentration of one per 10 nL of mix, corresponding to one bead for every droplet on average. As dictated by the Poisson distribution, 37% of the 10 nL droplets will contain only one microbead, the remaining containing either none or two plus.
- Each droplet, as discussed, is then optically scanned to determine the number of beads it contains.
- the valve 1009 is opened, passing the droplet to waste.
- Approximately one third of the droplets will contain a single bead and are routed to the main channel; thus, the average flow rate is equal to about 1 droplet every 1.5 s.
- every droplet in the main channel contains a single microbead, and one in ten also contains a single template molecule.
- the timing arrangement is based on the fact that the fluid in the distribution channel is incompressible. As such, the location of a microsphere within the distribution channel, for instance, adjacent to an inlet of a thermal cycling chamber, can be calculated from the time that the microsphere has been in the distribution channel. This is advantageous because the valved entrances to each of the 96 inputs from the distribution channel, for example, can be actuated by a single pneumatic input. Also the pneumatic input is not actuated until a detected bead is flowed directly opposite a reactor that does not have a bead yet.
Abstract
Methods and apparatus for genome analysis are provided. A microfabricated structure including a microfluidic distribution channel is configured to distribute microreactor elements having copies of a sequencing template into a plurality of microfabricated thermal cycling chambers. A microreactor element may include a microcarrier element carrying the multiple copies of the sequencing template. The microcarrier element may comprise a microsphere. An autovalve at an exit port of a thermal cycling chamber, an optical scanner, or a timing arrangement may be used to ensure that only one microsphere will flow into one thermal cycling chamber wherein thermal cycling extension fragments are produced. The extension products are captured, purified, and concentrated in an integrated oligonucleotide gel capture chamber. A microfabricated component separation apparatus is used to analyze the purified extension fragments. The microfabricated structure may be used in a process for performing sequencing and other genetic analysis of DNA or RNA.
Description
- This application is a continuation of and claims priority to U.S. application Ser. No. 11/139,018, filed May 25, 2005 (Atty. Docket No. UCALP054), titled “MICROFABRICATED INTEGRATED DNA ANALYSIS SYSTEM,” which claims the benefit under 35 U.S.C. 119(e) from Provisional U.S. Patent Application No. 60/576,102, filed Jun. 1, 2004 (Atty. Docket No. UCALP054P), entitled “MICROBEAD INTEGRATED DNA ANALYSIS SYSTEM (MINDS),” all of which are incorporated herein by reference for all purposes.
- The invention was made with government support under Grant Numbers AI056472, CA77664, and HG001399 awarded by the National Institute of Health. The government has certain rights in this invention.
- 1. Field of Invention
- The present invention relates to microfabricated and microfluidic structures. In one example, the present invention relates to a microfabricated system and method for genome sequencing.
- 2. Description of Related Art
- The genome of an organism is defined by the DNA (deoxyribonucleic acid) or, for some viruses, the RNA (ribonucleic acid) of the organism. Genome sequencing is figuring out the order of the nucleotides, or bases, of a DNA or RNA strand.
- A current approach to genome-scale sequencing of DNA is shown in
FIG. 1 . Thisshotgun sequencing approach 100 uses bacterial transformation, selection and growth to manipulate individual genomic DNA fragments. The first three steps of this approach, shearing, vector ligation, and transformation (steps - Therefore, it is desirable to improve the processing time, volume scale, and level of integration of genome sequencing. It is also desirable to reduce the cost and space requirements of genome sequencing.
- In one aspect, the invention features a microfabricated structure including a distribution channel to distribute microreactor elements carrying multiple copies of a clonal sequencing template into a plurality of thermal cycling chambers. Only one microreactor element is passed into one thermal cycling chamber wherein thermal cycling extension fragments are produced from a microreactor element. Purification chambers are connected to the thermal cycling chambers to capture and concentrate the extension fragments. Component separation channels are connected to the purification chambers to analyze the extension fragments.
- Various implementations of the invention may include one or more of the following features. The microreactor includes a microcarrier element that carries the multiple copies of the clonal sequencing template. The microreactor element is a bolus or microemulsion droplet. The microreactor element includes a microsphere carrying the multiple copies of the clonal sequencing template. The sequencing template is a DNA or RNA sequencing template.
- In yet another aspect, the invention is directed to a system for performing sequencing. The system includes a means for shearing DNA or RNA into fragments and means for ligating the fragments to form a mixture of desired circular and contaminating linear products. The system further includes means for selectively removing the contaminating linear products and means for generating microreactor elements carrying multiple clonal copies of a single sequencing template. The system also includes means for selecting which microreactor elements have a sequencing template and microfluidic distribution means for distributing a selected microreactor element with a sequencing template into a thermal cycling chamber. Additionally, the system includes means for ensuring that only one microreactor element will flow into one thermal cycling chamber and extension means, including the thermal cycling chambers, for producing thermal cycling extension fragments from the microreactor elements carrying multiple copies of the sequencing template. Purification chamber means for capturing, purifying and concentrating the extension fragments, and component separation means for analyzing the extension fragments are also part of the system.
- Other implementations of the invention may include one or more of the following features. The microreactor element includes a microcarrier element that carries the multiple copies of the clonal sequencing template. The microreactor element is a bolus or a microemulsion droplet. The microreactor element includes a microsphere carrying the multiple copies of the sequencing template.
- In another aspect, the invention features a microfabricated structure including a distribution channel to distribute microspheres carrying multiple copies of a clonal sequencing template into a plurality of thermal cycling chambers. An autovalve is located at an exit port of a thermal cycling chamber to ensure that only one microsphere will flow into one thermal cycling chamber wherein thermal cycling extension fragments are produced from the microsphere. Purification chambers are connected to the thermal cycling chambers to capture and concentrate the extension fragments. Component separation channels are connected to the purification chambers to analyze the extension fragments.
- Various implementations of the invention may include one or more of the following features. The diameter of a microsphere is between about 1 and 100 microns. The diameter of a microsphere is about 10 microns. Each thermal cycling chamber is in fluid communication with a separation channel. The sequencing template is a DNA or RNA sequencing template.
- In still another aspect, the invention is directed to a microfabricated structure including a microfluidic distribution channel means for distributing a microsphere carrying a sequencing template into a thermal cycling chamber. Autovalving means are used to ensure that only one microsphere will flow into one thermal cycling chamber. Extension means, including the thermal cycling chamber, produce thermal cycling extension fragments from a microsphere carrying a sequencing template. Integrated purification chamber means are used for capturing, purifying and concentrating the extension fragments. Component separation means are used to analyze the extension fragments.
- Other implementations of the invention may include one or more of the following features. The extension means is a Sanger extension means including a plurality of thermal cycling chambers. The autovalving means includes an autovalve at an exit port of the thermal cycling chambers. Purification chamber means includes purification chambers connected to the thermal cycling chambers. The component separation means is a capillary array electrophoresis means including a plurality of microchannels connected to the purification chambers. The sequencing template is a DNA or RNA sequencing template.
- In a further aspect, the invention is directed to a microfabricated apparatus including a thermal cycling chamber. The thermal cycling chamber is configured to receive a microsphere carrying a clonal template. The chamber has an inlet port and an outlet port wherein the outlet port includes a constriction that is configured to trap a microsphere in the chamber and to substantially block further flow into the thermal cycling chamber.
- Various implementations of the invention may include one or more of the following features. The shape of the constriction is substantially circular or semicircular. A first value is located in an inlet channel in fluid communication with the inlet port and a second valve is located in an outlet channel in fluid communication with the outlet port. In operation, the second valve is closed before the first valve to move a microsphere out of the constriction and into a main body portion of the chamber before thermal cycling. A purification chamber is in fluid communication with the outlet port of the thermal cycling chamber and an outlet port of the purification chamber is in fluid communication with a component separation apparatus.
- In yet another aspect, the invention features a system for performing sequencing. The system includes means for shearing DNA or RNA into fragments and means for ligating the fragments to form a mixture of desired circular and contaminating linear products. The system further includes means for selectively removing the contaminating linear products and means for generating microspheres carrying multiple clonal copies of a single sequencing template. The system also includes means for selecting which microspheres have a sequencing template and microfluidic distribution channel means for distributing a selected microsphere with a sequencing template into a thermal cycling chamber. Additionally, the system includes means for ensuring that statistically only one microsphere will flow into one thermal cycling chamber. The system also includes extension means, including the thermal cycling chambers, for producing thermal cycling extension fragments from the microspheres carrying multiple copies of the sequencing template. Purification chamber means for capturing, purifying and concentrating the extension fragments, and component separation means for analyzing the extension fragments are also part of the system.
- Other implementations of the invention may include one or more of the following features. The ensuring means is at least one of an autovalve in the thermal cycling chamber, an optical detector, and a timing mechanism. The optical detector is an optical scanner that detects light scattered from a microsphere. The timing mechanism includes a pneumatic input located adjacent to an inlet of a thermal cycling chamber.
- In a further aspect, the invention features a system for performing DNA sequencing. The system includes means for shearing DNA into DNA fragments and means for ligating the DNA fragments to form a mixture of desired circular and contaminating linear products. The system also includes means for exonuclease degredation for selectively removing the contaminating linear products and emulsion PCR reaction means for generating microspheres carrying multiple clonal copies of a single DNA sequencing template. Additionally, the system includes fluorescent activated cell sorting (FACS) means for selecting which microspheres have a DNA sequencing template. Microfluidic distribution channel means are used to distribute a selected microsphere with a DNA sequencing template into a thermal cycling chamber. Autovalving means are used to ensure that statistically only one microsphere will flow into one thermal cycling chamber. Sanger extension means, including the thermal cycling chambers, are used to produce thermal cycling extension fragments from the microspheres carrying multiple copies of the DNA sequencing template. Integrated purification chamber means are used to capture, purify and concentrate the extension fragments, and capillary array electrophoresis means are used to analyze the extension fragments.
- In still another aspect, the invention is directed to a process for performing sequencing. The process includes shearing DNA or RNA into fragments, ligating the fragments to form a mixture of desired circular and contaminating linear products, and selectively removing the contaminated linear products. The process further includes generating microreactor elements carrying multiple clonal copies of a sequencing template, selecting which microreactor elements have a sequencing template, and distributing the microreactor elements with the sequencing template into thermal cycling chambers. Thermal cycling extension fragments are produced from the microreactor elements carrying the multiple copies of the sequencing template. The extension fragments are captured, concentrated, and analyzed.
- Various implementations of the invention may include one or more of the following features. The microreactor element includes a microcarrier element which carries the multiple copies of the clonal sequencing template. The microreactor element is a bolus or a microemulsion droplet. The microreactor element includes a microsphere carrying the multiple copies of the clonal sequencing template. The distributing step is done such that only one microreactor element will pass into one thermal cycling chamber. An autovalve is used at an exit port of the thermal cycling chambers to ensure that only one microreactor element will flow into one thermal cycling chamber. The generating step includes generating multiple clonal copies of a sequencing template by emulsion PCR reactions or by a flow through PCR process. The selecting step is FACS.
- In yet another aspect, the invention features a process for performing DNA sequencing. The process includes shearing DNA into DNA fragments, ligating the DNA fragments to form a mixture of desired circular and contaminating linear products, and selectively removing the contaminating linear products by exonuclease degredation. Microspheres carrying multiple clonal copies of a DNA sequencing template are generated by emulsion PCR reactions. The microspheres that have a DNA sequencing template are detected by FACS. The microspheres with the DNA sequencing template are distributed into thermal cycling chambers. An autovalve at an exit port of a thermal cycling chamber is used to ensure that statistically only one microsphere will flow into one thermal cycling chamber. Thermal cycling extension fragments are produced from the microspheres carrying multiple copies of the DNA sequencing template. The extension fragments are captured, purified, concentrated and analyzed.
- Various implementations of the invention may include one or more of the following features. The capturing step uses an oligonucleotide capture matrix.
- In still another aspect, the invention features a method for sequencing. The method includes receiving a microsphere carrying a clonal template at an inlet port of a thermal cycling chamber and using a constriction at an outlet port of the chamber to trap the microsphere in the chamber and substantially block further flow into the chamber.
- In a further aspect, the invention features a method for analysis including producing a microsphere carrying a sequencing template. The microsphere is located in a thermal cycling chamber by use of a constriction at an outlet port in the chamber such that further flow into the chamber is substantially blocked.
- Other implementations of the invention may include one or more of the following features. A first valve is located at an inlet port of the thermal cycling chamber and a second valve is located at an outlet port of the thermal cycling chamber such that the second valve may be closed before the first valve. As such, a microsphere is moved out of the constriction and into a main body portion of the thermal cycling chamber before thermal cycling.
- The invention can include one or more of the following advantages. The laborious bacterial manipulations required by shotgun genome sequencing are replaced with easily automated and integrated in vitro steps. As such, millions of manual or robotic colony picking operations are eliminated. All fluidic and temperature control structures necessary to produce, purify, and separate sequencing extension fragments are integrated on a microfabricated device. Significant cost, time, and space savings can be achieved. Other genetic analysis techniques can be performed.
- These and other features and advantages of the present invention will be presented in more detail in the following specification of the invention and the accompanying figures, which illustrate, by way of example, the principles of the invention.
- The invention may best be understood by reference to the following description taken in conjunction with the accompanying drawings that illustrate specific embodiments of the present invention.
-
FIG. 1 is a diagrammatic representation of the steps involved in a conventional genome-scale sequencing operation. -
FIG. 2 is a diagrammatic representation of the steps involved in a genome sequencing process in accordance with the present invention. -
FIG. 3 is a diagrammatic representation of a cloning process that may be used with the present invention. -
FIG. 4A is a diagrammatic representation of a single-channel microdevice in accordance with the present invention,FIG. 4B is an enlarged view of a portion of the device ofFIG. 4A , andFIG. 4C is a diagrammatic exploded view of the single-channel microdevice. -
FIGS. 5A , 5B, and 5C are fluorescent images of a device in accordance with the present invention during capture, wash, and sample injection, respectively, of extension fragments. -
FIG. 6A is a diagrammatic representation of a sequencing reaction chamber of a device in accordance with the present invention, including an enlarged view of a portion of the reaction chamber;FIG. 6B is a view alongline 6B-6B ofFIG. 6A ; andFIG. 6C is a diagrammatic representation of a constriction region of the reaction chamber ofFIG. 6A that is used to trap beads carrying the DNA to be sequenced. -
FIG. 7A is a bright field image of a constriction region of an empty sequencing reaction chamber,FIG. 7B is a bright field image of a constriction region of a sequencing reaction chamber filled with solution but with no microsphere at the constriction region, andFIG. 7C is a dark field image of a microsphere located at a constriction region of a sequencing reaction chamber. -
FIG. 8A is a diagrammatic representation of an alternate embodiment of a constriction region of a sequencing reaction chamber designed for bead capture, andFIG. 8B is a view alongline 8B-8B ofFIG. 8A . -
FIG. 9A is a diagrammatic representation of one quadrant of an integrated sequencing array system, andFIG. 9B is an enlarged view of a portion of the system ofFIG. 9A . -
FIG. 10A is a diagrammatic representation of a continuous flow through PCR microfabricated device;FIG. 10B is an enlarged view atlines 10B-10B ofFIG. 10A , illustrating a “T”-injector region of the microfabricated device; andFIG. 10C is an enlarged view atlines 10C-10C ofFIG. 10A , illustrating a portion of the channels of the microfabricated device. - Reference will now be made in detail to some specific embodiments of the present invention including the best modes contemplated by the inventor for carrying out the invention. Examples of these specific embodiments are illustrated in the accompanying drawings. While the invention is described in conjunction with these specific embodiments, it will be understood that it is not intended to limit the invention to the described embodiments. On the contrary, it is intended to cover alternatives, modifications, and equivalents as may be included within the spirit and scope of the invention as defined by the appended claims.
- In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. The present invention may be practiced without some or all of these specific details. In other instances, well known process operations have not been described in detail in order not to unnecessarily obscure the present invention.
- Furthermore, techniques and mechanisms of the present invention will sometimes be described in singular form for clarity. However, it should be noted that some embodiments can include multiple iterations of a technique or multiple applications of a mechanism unless noted otherwise.
- The system and method of the present invention will be described in connection with DNA sequencing. However, the system and method may also be used for RNA sequencing. Additionally, the system and method may be used for other genetic analysis of DNA or RNA.
- The system and method of the present invention uses microreactor elements such as a microemulsion droplet or a bolus which, in some embodiments, include a microcarrier element such as a microsphere or bead. The microcarrier element, contained within a bolus or a microemulsion droplet, is useful in capturing DNA or RNA products; that is, amplified DNA or RNA can be chemically linked to the microcarrier element. Alternatively, the amplified DNA or RNA may be carried by a microreactor element without the use of a microcarrier element. For instance, a PCR reaction may be done in a bolus or a microemulsion droplet, and then the resulting bolui or microemulsion droplets may be routed to the next step of the process.
- A microfabricated integrated DNA analysis system (MINDS) of the present invention provides a system and method that are readily compatible with microfluidic sample component separation devices. As shown by
FIG. 2 , theMINDS process 200, in one embodiment, begins with the shearing of DNA into DNA fragments (step 202). The fragments are then ligated to form a mixture of desired circular and contaminating linear products (step 204). The contaminating linear products are then selectively removed, for instance, by exonuclease degradation (step 206). A colony of microspheres carrying multiple clonal copies of a DNA sequencing template is next formed (step 208). The colony may be generated, for example, by emulsion PCR reactions. The microspheres having a DNA sequencing template are then identified (step 210). The microspheres may be identified by a fluorescence activated cell sorting (FACS) technique. Only one such run is required, and it may take 6 hours or less to complete. The microspheres with the DNA sequencing templates are then distributed into thermal cycling or sequencing reaction chambers where extension fragments are produced; thereafter, the fragments are purified and concentrated (step 212). The extension fragment are then analyzed by a sample component separation apparatus, for example, a CE device (step 214). - The MINDS method, process, and apparatus, in one embodiment, comprises a microfabricated structure on which thermal cycling, affinity capture, sample purification, and capillary array electrophoresis (CAE) components are integrated. As will be discussed, such a system includes a microfluidic distribution channel to distribute microspheres carrying multiple copies of a sequencing template into a plurality of thermal cycling or sequencing reaction chambers. An autovalve may be located at an exit port of the thermal cycling chambers to ensure that only one microsphere will flow into each chamber wherein thermal cycling extension fragments are produced from the microsphere. Purification chambers are connected to the thermal cycling chambers to capture, purify, and concentrate the extension fragments. Microfabricated CE separation channels are connected to the purification chambers to analyze the extension fragments.
- The present invention eliminates the laborious, expensive, and time consuming in vivo cloning, selection, colony isolation, and amplification steps of conventional sequencing. Instead, these steps are replaced with readily miniaturized and automated in vitro steps.
- Microspheres are ideal carriers, providing flexible control over size, surface, fluorescent, and magnetic properties. Miniaturization of a sequencing reaction chamber through microfabrication and the concomitant reduction in reagent volume makes possible the use of a single, clonal microsphere as a carrier for sufficient DNA sequencing template. This enables the use of a matched process flow that permits selection, amplification and sorting of clonal templates for direct integration with a nanoliter extension, clean-up and sequencing process.
-
FIG. 3 provides an overview of acloning process 300 that may be used with the MINDS. The process includes library creation and selection. In one embodiment, genomic DNA is isolated from whole blood and then sheared in a nebulizer generating DNA fragments (steps 302 and 304). The DNA fragments are then subjected to an enzymatic treatment to yield blunt-end DNA (step 306). Processed fragments are ligated into a vector yielding a mixture of desired circular and contaminating linear products (steps 308 and 310). Exonuclease degredation then selectively removes the insert and vector, the contaminating linear products, from the ligation product so that greater than about 95% of the remaining vectors contain inserts, the desired circular products (step 312). - The first five steps of the cloning process 300 (steps 302-310) follow standard library creation procedures. More specifically, Invitrogen (Carlsbad, Calif.) supplies a TOPO Subcloning Kit (#K7000-01) which is capable of generating a 1 to 6 Kb insert genomic shotgun library in two hours. The subcloning kit requires about 20 micrograms (μg) of genomic DNA that can be obtained from 1 mL of whole blood using Qiagen's (Oslo, Norway) Blood & Cell Culture DNA Mini Kit (#13323). The DNA is sheared in a nebulizer generating 1-6 Kb DNA fragments. The fragments are then subjected to an enzymatic treatment with T4 DNA and Klenow polymerases and calf intestinal phosphatase (CIP) to yield dephosphorylated blunt-end DNA. Processed fragments are next ligated into Invitrogen's pCR 4 Blunt-TOPO vector. Use of covalently linked vaccinia virus topoisomerase I to the cloning vector results in rapid and efficient ligation (a 5 minute room temperature ligation yields greater than 95% transformants) and permits dephosphorylation of the inserts prior to ligation thereby preventing chimeric clone formation.
- The final step in canonical library creation (step 312), which has been modified to be compatible with the in vitro MINDS process, is bacterial transformation and antibiotic selection. Exonuclease degredation selectively removes insert and vector from the desired ligation product. Lambda exonuclease (New England BioLabs #M0262S) can be used for this step as it degrades 5′-phosphorylated and non-phosphorylated double-stranded DNA but is unable to initiate DNA digestion at the nicks present in the vector after ligation. Assuming a pessimistic 1% recovery of the starting genomic DNA, the resulting library contains greater than 6,000 fold molecular excess needed for 10× sequence coverage, though this excess is reduced through dilution in the single-molecule PCR amplification step described later.
- A gel separation and band purification step can be performed after DNA shearing (step 304) if strict control over insert size is required for paired-end whole-genome de novo sequencing. Alternatively, insert size can be restricted using limiting extension times during PCR amplification or flow cytometric selection of microspheres within a narrow fluorescence intensity range. Labeling microsphere-clones with an intercalating dye, such as thiazole orange (TO), will yield a fluorescent signal proportional to amplicon size. Since flow cytometry is a step in the MINDS process, this is an appealing size-selection method that also eliminates the >5% recircularized vectors with the only drawback being reduced yield.
- The vector used in the subcloning kit may be optimized for sequencing with the T7 and T3 priming sites 33 bp (base pairs) away from the insertion site. Since the MINDS vector is free from biological constraints, the sequencing priming sites can be moved closer to the insert site and the pUC ori, fl ori, lacZ, and antibiotic resistance genes can be removed. Optimized acrydite capture sequences and homo-PCR priming sites can be inserted for improved sample clean-up and reduced primer-dimer formation.
- Sequencing in the MINDS process may use clonal template DNA attached to individual microspheres or beads. The clonal attachment is accomplished by linking one of the primers covalently to a microsphere.
- Clonal isolation of 1,000 to 100,000 DNA molecules through single-molecule amplification (for example microemulsion polonies) or combinatorial hybridization approaches has been demonstrated. See, Mitra, R. D., et al., “Digital genotyping and haplotyping with polymerase colonies”, Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(10): p. 5926-5931; Dressman, D., et al., “Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations”, Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(15): p. 8817-8822; and Brenner, S., et al., “Gene expression and analysis by massively parallel signature sequencing (MPSS) on microbead arrays”, Nature Biotechnology, 2000, 18(6): p. 630-634; each of which is hereby incorporated by reference. Conventional microchip sequencing requires approximately 1 billion template DNA molecules per reaction. Twenty billion extension fragments have been generated after 20× linear Sanger-sequencing amplification, representing a 20-fold excess for high signal-to-noise (S/N) detection using a confocal radial scanner (1 million fragments per band X 1,000 bands=1 billion molecules). This excess is necessary because a cross-injection process requires streaming extension fragments across the separation column until an equimolar mixture is obtained at the intersection and then injecting about 5% of the total sample. An affinity capture direct-injection strategy discussed below eliminates the 20-fold excess requiring only 50 million initial template copies.
- CPG Biotech (Lincoln Park, N.J.) produces a 5 micron (μm) controlled pore glass paramagnetic microsphere with a long chain alkylamine linker for covalent attachment to an amine modified primer that can consistently bind 80 million DNA molecules. Starting from a single DNA molecule, 30 cycles of PCR has a theoretical gain of 1 billion. In practice, the gain is lower due to less than 100% efficiency for each cycle, reduced enzyme activity in later cycles, and limiting reagents in pL scale reactions. To generate clonal microspheres, a single DNA molecule and a single primer-coupled microsphere must be placed in a PCR reactor. Efficient single-molecule PCR requires extremely small volume reactors (1-10 pL) to increase the effective concentration of a single DNA molecule. Approximately 30 million microsphere clones are needed to sequence a human-size genome. High-throughput combination of a single microsphere and DNA molecule in a chamber is possible using statistically dilute microemulsion solutions. If the DNA molecules and microspheres are each diluted such that one species is present in 10 times the reactor volume, there is a high probability (greater than 99%) of concurrence in 1% of the reactors. Because 99% of the reactors are non-productive, 100-fold more reactions (3 billion) are required to generate 30 million microsphere clones.
- Two possible approaches for generating large numbers of small volume reactions are microfabricated PCR devices and emulsion PCR. PCR devices, however, require thousands of runs to achieve the required 3 billion reactions. Emulsion PCR, on the other hand, has the ability to thermally cycle millions to billions of separate compartments in a single tube using a conventional thermal cycler. Clonal PCR amplicons attached to magnetic particles using emulsion PCR have been produced. On average, each microsphere contained greater than 10,000 250 bp amplicons, a value below the theoretical maximum of 600,000 amplicons based on the available nucleoside triphosphates in each 5 μdiameter compartment. Fifteen micron microemulsion PCR compartments have been demonstrated in which the maximum number of 1,000 bp amplicons is 5 million—a value ten times less than the minimum required 50 million initial template copies. This problem may be solved in a variety of ways:
- First, additional microemulsion PCR steps could be performed to increase the amount of DNA linked to the beads. Second, an additional non-reagent-limited amplification step may be necessary after the fluorescence flow cytometry step. Secondary PCR amplification can be performed in an on-chip, dual-use thermal cycling chamber in which paramagnetic microspheres are routed to individual reactors and magnetically retained. Fresh PCR mix is passed into the chambers and thermal cycled 15× to saturate each microsphere to the maximum of 80 million templates. In this case, the magnetic field is maintained as Sanger-sequencing reaction mix is washed into the chambers followed by solid-phase sequencing. Finally, the S/N of the scanner may be improved up to 10-fold enabling sequencing of about a 10-fold lower template than calculated above.
- Approximately 15 million 15 μm diameter compartments may be created in a 25 μL aqueous phase, 75 μL oil phase emulsion. Three billion compartments are required to generate 30 million coincident single DNA molecule and microsphere events. Thus, approximately two 100 μL 96-well plate reactions are required. When the reactions are complete, 30 million microsphere clones must be separated from a background of 300 million un-labeled microspheres.
- As noted, the beads having sequencing templates may be identified by FACS. A system that may be used is the BD FACS ArrayBioanalyzer System, available from BD Biosciences, San Jose, Calif. The BD FACSArray flow cytometer can process up to 15,000 events per second, enabling the isolation of all clones needed for 10× coverage of a 3 billion base genome in less than 6 hours. The beads will be treated with an intercalation dye, such as TO, that is nonfluorescent until intercalated into double-stranded DNA. The fluorescence intensity of TO is linearly proportional to the amount of DNA allowing for easy differentiation between beads that have amplified DNA and those that do not.
- A diagrammatic representation of a single-
channel microdevice 400 in accordance with the present invention is shown inFIGS. 4A , 4B, and 4C. The device may be fabricated as a four layer glass-glass-PDMS (polydimethysiloxane)-glass sandwich that incorporates microfluidic valves, heaters, resistive temperature detectors (RTDs), and all reaction, capture and clean-up, and CE structures. The device, in another configuration, may be fabricated as a glass-PDMS-glass-glass stack. A four layer microfabricated system including valves, heaters, RTDs, chambers, and CE structures is described in U.S. patent application Ser. No. 10/750,533, filed Dec. 29, 2003, entitled “Fluid Control Structures In Microfluidic Devices”, assigned to the Assignee of the subject application, and which is hereby incorporated by reference. - The
microdevice 400 is capable of performing all down-stream steps in the MINDS process including extension fragment production, reaction clean-up, and extension fragment separation (steps FIG. 2 ). Thedevice 400 includes a thermal cycling or sequencingreaction chamber 402, a capture orpurification chamber 404, and aCE system 406 includingseparation channels 407. As shown, these components of thedevice 400 are connected by various valves and channels. A heater (not shown), for example, a kapton heater, may be used to heat the contents of the thermal cycling chamber. The template of the chamber is monitored byRTDs 405. - As shown in
FIG. 4C , thedevice 400 includes three glass layers, including achannel layer 430, a vialayer 432, and amanifold layer 434. APDMS membrane layer 436 is provided between the vialayer 432 and themanifold layer 434. Thetop layer 430 contains the thermal cycling reactors, the capture chambers and the CE features. Thesecond layer 432 incorporates the RTDs on the top surface of the glass wafer and etched features on the bottom to form the valves and pumps with themembrane layer 436 below. Thelast layer 434 includes the heater, and completes the valve and pump structures with pneumatic actuation lines and displacement chambers. - In one method of operation, a sequencing master mix is loaded from a
port 408 of thedevice 400 through amicrovalve 410 into thethermal cycling chamber 402. The volume of thechamber 402 may be approximately 250 nano-liters (nL). The separation channels of theCE system 406 are filled with linear polyacrylimide from aport 412 to aport 414. The CE system may be a 16-centimeter (cm) hyperturn system. An acrydite capture matrix is loaded from aport 416 to aport 418 to fill thecapture chamber 404 and an interveningpinched chamber 419. After thermal cycling thechamber 402, extension fragments and residual reactants are electrokinetically driven through avalve 420 and achannel 422 into thecapture chamber 404. The captured extension fragments are then electrophoretically washed and injected into achannel 424 for separation by theCE system 406. - An advantage of this affinity capture, sample clean-up microdevice is that purified extension fragments may be retained in 1-10 nL at a concentration determined by the quantity of the acrydite monomer added during synthesis.
FIGS. 5A , 5B, and 5C display fluorescence images (where relative applied potentials are indicated by “+” and “−”) from the operation of amicrodevice 500 like that of thedevice 400 where thermal cycling, capture, wash (purification), and concentration of a sample as well as separation were performed. Specifically, an acrydite capture matrix was synthesized in a 2-mL solution of 5% w/v acrylamide, 1×TTE (50 mM Tris, 50 mM TAPS free acid, 1 mM EDTA, pH=8.4), and 20 nmol of the methacrylate-modified oligo (5′-Acrydite-ACTGGCCGTCGTTTTACAA-3′ (SEQ. ID NO. 1), TM=60.4 C, Operon Technologies, Emeryville, Calif.). The solution was sparged with argon for 2 hours prior to adding 0.015% w/v APS and TEMED to initiate polymerization. The polymerized capture matrix was then loaded into acapture chamber 504 using a 1 mL syringe. A polymer sequencing matrix (CEQ, Beckman Corp., Fullerton, Calif.) was loaded into aCE system 506 using a high-pressure gel loader. A C-track master mix was prepared containing 80 nM ET-primer, 1× C terminator mix (Amersham), and 4 nM PCR product and injected into a 250 nL thermal cycling chamber or reactor (not shown). Thermal cycling (35×, 94° C. 30 seconds, 45° C. 40 seconds, 70° C. 40 seconds) was performed on-chip using a LabVIEW program (National Instruments, Austin, Tex.). - Sequencing reaction clean-up was performed by first equilibrating the microdevice on a 50° C. heated stage for 30 seconds. Then, sample capture (
FIG. 5A ) was initiated by applying 2000 V to the capture chamber outlet (port 416 ofFIG. 4A ) while grounding the reactor inlet (port 408 ofFIG. 4A ). Thus, the sample containing extension fragments and residual nucleotides, primers, and salts was electrophoretically driven from the thermal cycling chamber through achannel 522 into thecapture chamber 504. Extension fragments hybridize to the Acrydite matrix in the capture chamber while residual reactants pass through. When oligonucleotide capture was complete, the retained extension fragments were electrophoretically washed (FIG. 5B ) for 30 seconds to remove excess primer and other contaminants still present in the capture chamber. After electrophoretic washing, the stage was ramped to 70° C. and equilibrated for 60 seconds to allow full denaturation of the product-matrix duplex. The denatured sample is directly injected intoseparation columns 507 of the CE apparatus 506 (FIG. 5C ) by applying 2,500 V to the anode while grounding the capture chamber outlet. (Images have been processed to highlight channel structure and remove fluorescent surface contamination.) - Alternatively, a straight cross-injector and a 30-cm separation capillary could be used. This will improve resolution.
- The microsphere-colony creation procedure and a single reactor microdevice can generate single-ended reads suitable for resequencing efforts. De novo whole-genome shotgun sequencing of complex genomes requires paired-end reads from short and long insert clones. Long-range PCR followed by fluorescent flow cytometry can be used on a subset of microspheres to selectively generate long-insert clones. Traditional paired-end sequencing requires procedural and microdevice modifications such that clonal DNA could be released from the microspheres and routed to separate forward and reverse sequencing reactors. An alternative strategy is to perform forward and reverse sequencing simultaneously on a subset of bases using an altered base labeling scheme. These paired-end reads generate long single or double-base reads suitable for anchoring four-base single-ended reads in the sequence assembly.
- As illustrated in
FIGS. 6A , 6B and 6C, amicrosphere 600 is used to transfer a clonal template into a thermal cycling or sequencingreaction chamber 602 where sequencing reactions are performed. This process requires that one microsphere be introduced in each sequencing reaction chamber. Autovalving techniques for trapping an individual microsphere in a sequencing reaction chamber, without the need for individually actuated valves and sensing, are used for this purpose. - As shown, the
reaction chamber 602 includes an introduction channel orarm 604 and an exit channel orarm 606. The introduction channel is in fluid communication with aninlet port 605 of the reaction chamber, while the exit channel is in fluid communication with anoutlet port 607 of the reaction chamber. Self-valving is achieved by creating a constriction orconstriction region 608 at the outlet end orport 607 of the reaction chamber. The constriction region is semicircular in shape. - The constriction will trap a microsphere before it exits the chamber. The trapped microsphere will produce a drop in the flow rate, thereby preventing any further microspheres from flowing into the chamber. The dilution of the microspheres will be chosen such that the probability that another microsphere flows into the reaction chamber before the first microsphere has blocked the chamber is below about 0.5%. If this statistical approach is unreliable or leads to low sorting rates, an on-chip sensor for bead light scattering can be used, and two valves in the sorting loop can be added to produce a more temporally uniform bead distribution.
- Glass fabrication processes can be used to create the device shown in
FIGS. 6A-6C . In one example, all features except the constriction were isotropically etched to a depth of 30 μm. The sample introduction and exit channels were set to 70 μm in width and 15 mm in length. The sequencing reaction chamber had a volume of 250 nL. After the basic fabrication process was completed for the channels and the reaction chamber, a second mask was used to fabricate the constriction. For this, a more viscous photoresist (SJR 5740, Shipley, Marlborough, Mass.) was spin-coated on a wafer at 2500 rpm for 35 seconds. This was followed by a soft bake at 70° C. for 7 minutes and 90° C. for 6 minutes. A higher viscosity photoresist gives more uniform coating on the featured wafer. The constriction pattern was transferred to the coated wafer using a contact printer. Alignment marks were used to align (±1 μm) the constriction with the already etched channels and chamber. After development, the amorphous silicon masking layer was removed via plasma etching, and the exposed glass was wet etched using 5:1 BHF with an effective etch rate of 2 μm/hour for 1.5 hours. This gave a constriction depth or height of 3 μm. The constriction width was set to 8 μm and the length was set to 15 μm. - Testing of the self-valving concept was performed using 6 μm diameter, Streptavidin Coated Fluoresbrite YG Carboxylated Polystyrene microspheres (Polysciences Inc., Warrington, Pa.) suspended in a solution of 1× Tris (pH 8.0) and 1% Triton X-100 diluted to a final concentration of 1 microsphere/3 μL. Using the Poisson distribution, it was calculated that a 10× dilution of the reaction chamber volume will insure that the probability that another microsphere will enter the 250 nL chamber before the first microsphere blocks the constriction is below 0.5%.
- A device like that shown in
FIGS. 6A-6C was pre-filled with a solution of 1× Tris (pH 8.0) and 1% Triton X-100. The microsphere solution (6 μL) was pipetted into an inlet access hole. A vacuum line was used to draw the beads through the chamber. The pressure drop increased from −60 kPa to −70 kPa when a microsphere was trapped at the constriction, and blockage occurred within the first 60 seconds. The experiment was continued for 12 minutes and no other microsphere was observed to enter the chamber. -
FIGS. 7A and 7B show bright field images of aconstriction region 708 of athermal cycling chamber 702 at 20× magnification when empty and with solution (but no microsphere), respectively.FIG. 7C shows a dark field image of thethermal cycling chamber 702 with afluorescent microsphere 700 trapped at theconstriction 708 and acting as a valve. The experiments were performed for microspheres of approximately 6 μm diameter. The concept is easily scalable to larger microspheres to increase the number of templates in the reactor. Also, smaller microsphere could be used. The microspheres, in particular, may be between about 1 and 100 μm in diameter. In one embodiment, they are about 10 μm in diameter. - An alternative autovalving embodiment, which will result in complete flow blockage, is presented in
FIGS. 8A and 8B . Here, areaction chamber 802 has a near circular constriction orconstriction region 808 formed at achamber outlet port 807. The chamber and the constriction will be double-etched; that is, they will be etched on both of two joined glass surfaces. This will produce a near circular constriction, as opposed to a semicircular constriction of the embodiment ofFIGS. 6A-6C . This will provide better valving for trapping amicrosphere 800. - As discussed, valves will be incorporated on either side of a sequencing reaction or thermal cycling chamber 402 (see
FIGS. 4A and 4B ). Once a microsphere has been trapped at the constriction, it needs to be pushed back into the chamber for thermal cycling so that there is good accessibility of the clonal templates to the polymerase, primers, dNTPs and ddNTPs. By closing thevalve 420 at the outlet of the chamber before closing theinlet valve 410, the microsphere will be pushed back into the chamber as a result of the finite dead volume of the valves. This principle is easily scaled to an array system by actuating the inlet and outlet valves in parallel. - To realize a high-throughput and fully integrated system for DNA analysis, a microfabricated array of integrated analyzers that incorporate thermal cycling chambers, purification chambers as well as separation channels for CE analysis of the sequencing fragments is provided. A schematic of such a
system 900 is shown inFIGS. 9A and 9B . This system extends the single channel device ofFIGS. 4A-4C to an array structure that is able to perform highly parallel analyses. - According to various embodiments, the
system 900 includes multiplethermal cycling chambers 902 and associated sample purification or capturechambers 904 arranged about a circular axis to form a radially parallel system. The thermal cycling chambers and the sample purification chambers are all integrated with aCE analyzer system 906 including separation channels ormicrochannels 908. The CE analyzer has a common central anode (A) 910, a cathode reservoir (C) 912, and a waste reservoir (W) 914. The cathode and anode reservoirs are associated with adjacent sets ofseparation channels 908. Themicrochannels 908 are connected to theanode 910 for detection using a rotary confocal fluorescence scanner of the type discussed in the article entitled: “High-throughput genetic analysis using microfabricated 96-sample capillary array electrophoresis microplates”, Peter C. Simpson, et al., Proc. Natl. Acad. Sci. USA, Vol. 95, pp. 2256-2261, March 1998, which is hereby incorporated by reference. - The
system 900 further includes adistribution channel 916,integrated heaters RTDs 920. Theheaters - The temperature of these reactions are monitored by the RTDs. In one embodiment, four-equally spaced RTDs are integrated on the substrate to provide precise temperature sensing across the
heater 918 a for optimal thermal cycling performance. Similarly, four-equally spaced RTDs may be used to monitor the temperature of theheater 918 b. - The
system 900 also includes an array of integrated valves and ports for controlling the system flow process. The valves may be monolithic elastomer (PDMS) membrane valves. The system may be fabricated as described in the above-identified U.S. patent application Ser. No. 10/750,533, which has been incorporated by reference. As such, the system may include a four layer glass-glass-PDMS-glass stack that incorporates the microfluidic valves and pumps, the RTDs, the thermal cycling chambers, the clean-up and concentration chambers, and the CE channels. - The
system 900, in one embodiment, includes 24 thermal cycling chambers, 24 purification chambers, and 24 CE channels arranged on a quadrant of a 150-mm diameter glass substrate. Each thermal cycling chamber (˜250 nL) is isolated from the distribution channel by PDMS membrane valves (V1) 922. Rigid containment of the chamber volume with active valves is necessary for bubble-free loading and immobilization of a sample during thermal cycling since sample movement, bubble formation, and sample evaporation can seriously affect the performance. - The RTDs may be fabricated of titanium (Ti) and platinum (Pt). Different materials (Au, Al, Pt, Ni) using different metal deposition techniques, such as sputtering and both thermal and electron-beam evaporations, may be used to fabricate the heaters. Nickel heaters exhibit good heating uniformity, have good scratch resistance, show no noticeable degradation of performance even after hundreds of thermal cycles, and are easily fabricated. The microfabricated heaters and the thermal cycling chambers are positioned away from the CE microchannels to avoid evaporation of buffer in the cathode reservoirs and to minimize the heating of the injection region during thermal cycling. The resistive ring heaters can be fabricated on the back side of the bottom wafer to ensure good thermal transfer between the heaters and the chambers. The equally-spaced RTDs are integrated on the microplate to provide precise temperature sensing ensuring temperature uniformity across the heaters for optimal performance.
- The thermal cycling chambers may be cycled with a LabVIEW program (National Instruments, Austin, Tex.). (LabView VI) Temperature control can be accomplished through a proportion/integration/differentiator (PID) module within the LabVIEW program.
- In operation, in one embodiment, a sequencing separation matrix is introduced into the CE separation channels using positive pressure through the
anode 910. A separation matrix fills thecathode reservoirs 912 and thewaste reservoirs 914, as well asarms 924 connecting the cross-injection point to the associated sample purification chambers. The filling rate can be modulated through adjustment of the widths and lengths of the various interconnecting channels. The cathode and anode reservoirs, and the connecting arms may be filled at the same rate. Water, for example, is loaded from a loading (L)port 926 connected to thedistribution channel 916 to fill thethermal cycling chambers 902 and thesample purification chambers 904 ensuring continuity for subsequent processes. An exit port (E) 936 is shared by both thethermal cycling chambers 902. - A capture gel matrix is loaded into the sample purification chambers through ports (F) 928. Libraries of clonal DNA beads that have been sorted and prepared using a FACS unit are loaded from the port 926 (valves (V1) 922 and (V2) 930 open, and valve (V3) 932 closed) using, for example, a syringe pump. A pressure transducer is employed in the inlet to monitor the head pressure. Auto-valves at the exit ports of the thermal cycling chambers will stop the flow into a chamber once a bead is trapped in the auto-valve as described above. As each auto-valve is filled with a bead in each thermal cycling chamber, the head pressure will continue to increase. In this manner, loading a bead in each thermal cycling chamber is achieved by monitoring the head pressure.
- Upon filling the chambers, the valves (V2) 930 and (V1) 922 are closed and thermal cycling reactions initiated. Since the beads will be sorted directly in the thermal cycling cocktail, no additional steps are needed before thermal cycling. Alternatively, sorting could be performed in a buffer followed by introduction of the thermal cycling cocktail into the thermally cycling chambers to minimize reagent usage. The
heaters RTDs 920. - Thermal cycling products are driven to the purification chambers by applying an electric field across the port (L) 926 and a sample port or electrical contact point (S) 934 with the valves (V1) 922 and (V3) 932 open. Flushing of the non-captured reagents is performed by applying an electric field between the port (S) 934 and the port (F) 928. Thereafter, the sequencing products are injected from the purification chambers into the associated
microchannels 908 for CE separation, by applying a potential between the port (S) 934 and the waste reservoir (W) 914. The rotary confocal fluorescence scanner is used to detect the sequencing samples. The scanner interrogates the channels sequentially in each rotation of the scanner head. - As shown, separations of the purified DNA sequencing products are achieved by using cross-injection. Alternatively, direct injection could be used.
- In another embodiment, the microemulsion PCR approach of colony formation is replaced by a continuous flow through PCR technique in which bolui or droplets for performing single-molecule PCR amplification of templates are formed and then amplified. The bolui or plugs are formed, for example, by combining an aqueous solution of PCR reagents and dilute template fragments with a hydrophobic solution that acts as a carrier. The bolui produced by this technique will contain statistically a small number of copies of a sequencing template. Ideally the concentration is chosen so that only one in 10 bolui contain a single sequencing template. This mean that only one in 100 will simultaneously contain undesirably two templates. A microsphere or bead carrying one of the primers in the PCR reaction can also be entrained within a bolus or droplet in the process of performing this technique. Thus, a colony may comprise bolui carrying multiple clonal copies of a single sequencing template or bolui having microspheres carrying such copies.
- As shown in
FIGS. 10A , 10B, and 10C, a continuous flow throughmicrofabricated PCR system 1000 includesports injector region 1006 via theport 1002, while a hydrophobic carrier solution is introduced into the “T”-injector region via theport 1004. A bolus ordroplet 1012 containing a microsphere is thus formed downstream of the “T”-injector region. - The
system 1000 further includes an optical sensor 1007 (FIG. 10B ) located downstream of the “T”-injector near an input end of achannel 1014. The sensor may comprise a focused laser beam and a photodiode to detect off-axis light scattering. - The sensor is configured to select a bolus that contains a bead and to reject bolui with no bead or with more than one bead. A rejected bolus is passed out of the system via a
valve 1009 and a waste port andchannel 1011. Thevalve 1009 may be a four-layer PDMS valve that when open allows a rejected bolus to exit the system via thewaste port 1011. The valve may be activated via avalve actuation port 1013. Since the fluidic resistance of the continuous flow system is so great, no valve is needed in themain channel 1014. - The
system 1000 is designed for two-step PCR where the anneal and extend steps are combined. As such, the system includes twotemperature zones droplets 1012 pass via the flow throughchannels 1014. Thedevice 1000 includesRTDs 1016 and associatedRTD contact pads 1018 for monitoring the temperature of the different temperature zones. A bolus and microsphere, after undergoing two-temperature PCR, exit the system via anexit port 1020. - As discussed, the microsphere can be treated with an intercalation dye, such as TO, that is nonfluorescent until intercalated into double-stranded DNA. Therefore, the microspheres that have amplified DNA can be identified by, for example, the FACS technique after they pass through the
port 1020. Thereafter, the microspheres are introduced into a distribution channel of a device like the device 900 (SeeFIGS. 9A and 9B ). The microspheres that do not have amplified DNA, on the other hand, will be disposed of. - The continuous flow through
PCR system 1000, in one example, uses nanoliter droplets of PCR reagents suspended in a perfluorohydrocarbon carrier. See, Song, H., et al., “A microfluidic system for controlling reaction networks in time”, Angewandte Chemie-International Edition 42, 768-772 (2003), which is hereby incorporated by reference. Droplets containing microspheres, PCR reagents, and template fragments, separated from one another by an immiscible liquid, are formed at the microfabricated T-injector 1006. Thereafter, the droplets flow through theregions channels 1014 in thedifferent temperature zones - The
device 1000 may comprise two 1.1-mm thick by 10-cm diameter borofloat glass wafers. The channels on the patterned wafer may have a D-shape cross-section with a width of about 210 μm and a depth of about 95 μm. On the other wafer, Ti/Pt RTDs may be fabricated for monitoring temperature gradients at different points in the device. Holes may be drilled for accessing the channels, and the two wafers may be thermally bonded to each other to form enclosed channels. Thenanoports FIG. 10B shows the droplet formation process at the T-injector at about 1 droplet/s, andFIG. 10C shows the droplets as they move through the channel. - The technique, in one embodiment, uses microbeads in 10 nL droplets. Throughput is maintained at one in ten droplets containing both a single template molecule and a single bead. The aqueous PCR mix is prepared such that there is one template molecule per 100 nL of mix, corresponding to one molecule for every ten droplets. Also in the PCR mix are microbeads at a concentration of one per 10 nL of mix, corresponding to one bead for every droplet on average. As dictated by the Poisson distribution, 37% of the 10 nL droplets will contain only one microbead, the remaining containing either none or two plus. Each droplet, as discussed, is then optically scanned to determine the number of beads it contains. If the droplet does not contain a single microbead, the
valve 1009 is opened, passing the droplet to waste. Approximately one third of the droplets will contain a single bead and are routed to the main channel; thus, the average flow rate is equal to about 1 droplet every 1.5 s. As such, every droplet in the main channel contains a single microbead, and one in ten also contains a single template molecule. - At the end of the
device 1000, the droplets may be collected at theport 1020 via a standard capillary into a microfuge tube. The droplets are broken through centrifugation. Microbeads are collected and washed in 1×TE, again through centrifugation. The microbeads are routed into the thermal cycling chambers of thedevice 900 by either autovalving or active valving with on-chip detection. On-chip detection may comprise the use of an optical scanner or a timing arrangement that determines when a microsphere is located adjacent to an inlet of a thermal cycling chamber. The optical scanner, as discussed, may use bead light scattering to determine the location of a microsphere within the distribution channel. The timing arrangement is based on the fact that the fluid in the distribution channel is incompressible. As such, the location of a microsphere within the distribution channel, for instance, adjacent to an inlet of a thermal cycling chamber, can be calculated from the time that the microsphere has been in the distribution channel. This is advantageous because the valved entrances to each of the 96 inputs from the distribution channel, for example, can be actuated by a single pneumatic input. Also the pneumatic input is not actuated until a detected bead is flowed directly opposite a reactor that does not have a bead yet. - To demonstrate the feasibility of generating sequencing templates using two-temperature PCR, high-temperature primers were designed and tested in a conventional thermal cycler. Two primers, M13—2T_F—5′TTCTGGTGCCGGAAACCAGGCAAAGCGCCA-3′(SEQ. ID NO. 2) Tm=70.3° C. and M13—2T_R 5′-ACGCGCAGCGTGACCGCTACACTTGCCA-3′ (SEQ. ID NO. 3) Tm=70.7° C. were designed to generate a 943 bp amplicon from the M13 genome. To approximate the concentration of a single template molecule in a 11 nL emulsion compartment, 18.75 femtograms of M13 template were cycled in a 25 uL PCR reaction (94° C. 1.5 min followed by 50 cycles of 94° C. 10 s, 70° C. 30 s with an auto-extend of 1 s/cycle). The resulting amplicon was a single clean peak at the expected size with a yield of about 40 ng/uL.
- If such a system is used to amplify genomic DNA, for 1× coverage and average fragment size of 1000 bps, about 3 million fragments need to be amplified. The probability that two different fragments end up in a single droplet can be reduced to less than 0.01 by diluting the fragments in the PCR reagent such that on an average one in ten droplets contains a fragment. Hence, the system will have to process 30 million droplets. This device is designed to generate one droplet about every 1.5 seconds. If 20 such devices are run in parallel, the entire genome can be amplified and interfaced with a bank of the
sequencing systems 900 to produce 1× coverage in only one month. - While the invention has been particularly shown and described with reference to specific embodiments, it will also be understood by those skilled in the art that changes in the form and details of the disclosed embodiments may be made without departing from the spirit or scope of the invention. For example, the embodiments described above may be implemented using a variety of materials. Therefore, the scope of the invention should be determined with reference to the appended claims.
Claims (15)
1. A microfabricated structure comprising:
a distribution channel to distribute microreactor elements carrying multiple copies of a clonal sequencing template into a plurality of thermal cycling chambers such that only one microreactor element will pass into one thermal cycling chamber wherein thermal cycling extension fragments are produced from a microreactor element;
purification chambers connected to the thermal cycling chambers to capture and concentrate the extension fragments; and
component separation channels connected to the purification chambers to analyze the extension fragments.
2. The microfabricated structure of claim 1 wherein the microreactor element includes a microcarrier element that carries the multiple copies of the clonal sequencing template.
3. The microfabricated structure of claim 1 wherein the microreactor element is a bolus or a microemulsion droplet.
4. The microfabricated structure of claim 3 wherein the microreactor element includes a microsphere carrying the multiple copies of the clonal sequencing template.
5. The microfabricated structure of claim 1 wherein the sequencing template is a DNA or RNA sequencing template.
6. A system for performing sequencing comprising:
means for shearing DNA or RNA into fragments;
means for ligating the fragments to form a mixture of desired circular and contaminating linear products;
means for selectively removing the contaminating linear products;
means for generating microreactor elements carrying multiple clonal copies of a single sequencing template;
means for selecting which microreactor elements have a sequencing template;
microfluidic distribution means for distributing a selected microreactor element with a sequencing template into a thermal cycling chamber;
means for ensuring that only one microreactor element will flow into one thermal cycling chamber;
extension means, including the thermal cycling chambers, for producing thermal cycling extension fragments from the microreactor elements carrying multiple copies of the sequencing template;
purification chamber means for capturing, purifying and concentrating the extension fragments; and
component separation means for analyzing the extension fragments.
7. The system of claim 6 wherein the microreactor element includes a microcarrier element that carries the multiple copies of the clonal sequencing template.
8. The system of claim 6 wherein the microreactor element is a bolus or a microemulsion droplet.
9. The system of claim 8 wherein the microreactor element includes a microsphere carrying the multiple copies of the clonal sequencing template.
10. A microfabricated structure comprising:
a distribution channel to distribute microspheres carrying multiple copies of a clonal sequencing template into a plurality of thermal cycling chambers;
an autovalve at an exit port of a thermal cycling chamber to ensure that only one microsphere will flow into one thermal cycling chamber wherein thermal cycling extension fragments are produced from a microsphere;
purification chambers connected to the thermal cycling chambers to capture and concentrate the extension fragments; and
component separation channels connected to the purification chambers to analyze the extension fragments.
11. The microfabricated structure of claim 10 wherein the diameter of a microsphere is between about 1 and 100 microns.
12. The microfabricated structure of claim 11 wherein the diameter of a microsphere is about 10 microns.
13. The microfabricated structure of claim 10 wherein each thermal cycling chamber is in fluid communication with a separation channel.
14. The microfabricated structure of claim 10 wherein the sequencing template is a DNA or RNA sequencing template.
15-44. (canceled)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/844,544 US20110020920A1 (en) | 2004-06-01 | 2010-07-27 | Microfabricated integrated dna analysis system |
US13/372,376 US8420318B2 (en) | 2004-06-01 | 2012-02-13 | Microfabricated integrated DNA analysis system |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57610204P | 2004-06-01 | 2004-06-01 | |
US11/139,018 US7799553B2 (en) | 2004-06-01 | 2005-05-25 | Microfabricated integrated DNA analysis system |
US12/844,544 US20110020920A1 (en) | 2004-06-01 | 2010-07-27 | Microfabricated integrated dna analysis system |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/139,018 Continuation US7799553B2 (en) | 2004-06-01 | 2005-05-25 | Microfabricated integrated DNA analysis system |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/372,376 Division US8420318B2 (en) | 2004-06-01 | 2012-02-13 | Microfabricated integrated DNA analysis system |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110020920A1 true US20110020920A1 (en) | 2011-01-27 |
Family
ID=35463468
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/139,018 Active US7799553B2 (en) | 2004-06-01 | 2005-05-25 | Microfabricated integrated DNA analysis system |
US12/844,544 Abandoned US20110020920A1 (en) | 2004-06-01 | 2010-07-27 | Microfabricated integrated dna analysis system |
US13/372,376 Active US8420318B2 (en) | 2004-06-01 | 2012-02-13 | Microfabricated integrated DNA analysis system |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/139,018 Active US7799553B2 (en) | 2004-06-01 | 2005-05-25 | Microfabricated integrated DNA analysis system |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/372,376 Active US8420318B2 (en) | 2004-06-01 | 2012-02-13 | Microfabricated integrated DNA analysis system |
Country Status (5)
Country | Link |
---|---|
US (3) | US7799553B2 (en) |
EP (1) | EP1774042A4 (en) |
JP (1) | JP2008500836A (en) |
KR (1) | KR101214270B1 (en) |
WO (1) | WO2005118867A2 (en) |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090060797A1 (en) * | 2002-12-30 | 2009-03-05 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
US20090253181A1 (en) * | 2008-01-22 | 2009-10-08 | Microchip Biotechnologies, Inc. | Universal sample preparation system and use in an integrated analysis system |
US20100068723A1 (en) * | 2004-09-15 | 2010-03-18 | Stevan Bogdan Jovanovich | Microfluidic devices |
US20100165784A1 (en) * | 2008-12-31 | 2010-07-01 | Microchip Biotechnologies, Inc., A California Corporation | Instrument with microfluidic chip |
US20100285975A1 (en) * | 2007-07-24 | 2010-11-11 | The Regents Of The University Of California | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions |
US20100303687A1 (en) * | 2009-06-02 | 2010-12-02 | Integenx Inc. | Fluidic devices with diaphragm valves |
US20110039303A1 (en) * | 2007-02-05 | 2011-02-17 | Stevan Bogdan Jovanovich | Microfluidic and nanofluidic devices, systems, and applications |
US20110076735A1 (en) * | 2004-09-15 | 2011-03-31 | Jovanovich Stevan B | Microfluidic Devices |
US20110126911A1 (en) * | 2009-12-01 | 2011-06-02 | IntegenX Inc., a California Corporation | Composite Plastic Articles |
US20110223605A1 (en) * | 2009-06-04 | 2011-09-15 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for DNA analysis |
US8286665B2 (en) | 2006-03-22 | 2012-10-16 | The Regents Of The University Of California | Multiplexed latching valves for microfluidic devices and processors |
US8420318B2 (en) | 2004-06-01 | 2013-04-16 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
US8763642B2 (en) | 2010-08-20 | 2014-07-01 | Integenx Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
US8841116B2 (en) | 2006-10-25 | 2014-09-23 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
US8961764B2 (en) | 2010-10-15 | 2015-02-24 | Lockheed Martin Corporation | Micro fluidic optic design |
US9121058B2 (en) | 2010-08-20 | 2015-09-01 | Integenx Inc. | Linear valve arrays |
US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
Families Citing this family (185)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6432290B1 (en) | 1999-11-26 | 2002-08-13 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
CA2290731A1 (en) | 1999-11-26 | 2001-05-26 | D. Jed Harrison | Apparatus and method for trapping bead based reagents within microfluidic analysis system |
US6692700B2 (en) | 2001-02-14 | 2004-02-17 | Handylab, Inc. | Heat-reduction methods and systems related to microfluidic devices |
US7829025B2 (en) | 2001-03-28 | 2010-11-09 | Venture Lending & Leasing Iv, Inc. | Systems and methods for thermal actuation of microfluidic devices |
US7010391B2 (en) | 2001-03-28 | 2006-03-07 | Handylab, Inc. | Methods and systems for control of microfluidic devices |
US6852287B2 (en) | 2001-09-12 | 2005-02-08 | Handylab, Inc. | Microfluidic devices having a reduced number of input and output connections |
US8895311B1 (en) | 2001-03-28 | 2014-11-25 | Handylab, Inc. | Methods and systems for control of general purpose microfluidic devices |
US20070166725A1 (en) * | 2006-01-18 | 2007-07-19 | The Regents Of The University Of California | Multiplexed diagnostic platform for point-of care pathogen detection |
US7329545B2 (en) | 2002-09-24 | 2008-02-12 | Duke University | Methods for sampling a liquid flow |
US6911132B2 (en) | 2002-09-24 | 2005-06-28 | Duke University | Apparatus for manipulating droplets by electrowetting-based techniques |
US20060078893A1 (en) * | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
AU2004273783A1 (en) | 2003-07-12 | 2005-03-31 | Accelr8 Technology Corporation | Sensitive and rapid biodetection |
EP2402089A1 (en) | 2003-07-31 | 2012-01-04 | Handylab, Inc. | Processing particle-containing samples |
US8852862B2 (en) | 2004-05-03 | 2014-10-07 | Handylab, Inc. | Method for processing polynucleotide-containing samples |
GB0421529D0 (en) | 2004-09-28 | 2004-10-27 | Landegren Gene Technology Ab | Microfluidic structure |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
JP5897780B2 (en) | 2005-01-28 | 2016-03-30 | デューク ユニバーシティ | Apparatus and method for operating droplets on a printed circuit board |
WO2007081385A2 (en) | 2006-01-11 | 2007-07-19 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
US7749365B2 (en) | 2006-02-01 | 2010-07-06 | IntegenX, Inc. | Optimized sample injection structures in microfluidic separations |
US10900066B2 (en) | 2006-03-24 | 2021-01-26 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
EP2001990B1 (en) | 2006-03-24 | 2016-06-29 | Handylab, Inc. | Integrated system for processing microfluidic samples, and method of using same |
US11806718B2 (en) | 2006-03-24 | 2023-11-07 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
US7998708B2 (en) | 2006-03-24 | 2011-08-16 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
US8883490B2 (en) | 2006-03-24 | 2014-11-11 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
US8613889B2 (en) * | 2006-04-13 | 2013-12-24 | Advanced Liquid Logic, Inc. | Droplet-based washing |
US8637317B2 (en) * | 2006-04-18 | 2014-01-28 | Advanced Liquid Logic, Inc. | Method of washing beads |
US8492168B2 (en) | 2006-04-18 | 2013-07-23 | Advanced Liquid Logic Inc. | Droplet-based affinity assays |
US9476856B2 (en) | 2006-04-13 | 2016-10-25 | Advanced Liquid Logic, Inc. | Droplet-based affinity assays |
US20140193807A1 (en) | 2006-04-18 | 2014-07-10 | Advanced Liquid Logic, Inc. | Bead manipulation techniques |
US8980198B2 (en) | 2006-04-18 | 2015-03-17 | Advanced Liquid Logic, Inc. | Filler fluids for droplet operations |
US7816121B2 (en) | 2006-04-18 | 2010-10-19 | Advanced Liquid Logic, Inc. | Droplet actuation system and method |
US7901947B2 (en) | 2006-04-18 | 2011-03-08 | Advanced Liquid Logic, Inc. | Droplet-based particle sorting |
US8470606B2 (en) * | 2006-04-18 | 2013-06-25 | Duke University | Manipulation of beads in droplets and methods for splitting droplets |
ATE490971T1 (en) * | 2006-04-18 | 2010-12-15 | Advanced Liquid Logic Inc | BIOCHEMISTRY ON DROPLETS |
US7815871B2 (en) | 2006-04-18 | 2010-10-19 | Advanced Liquid Logic, Inc. | Droplet microactuator system |
US8658111B2 (en) | 2006-04-18 | 2014-02-25 | Advanced Liquid Logic, Inc. | Droplet actuators, modified fluids and methods |
US8809068B2 (en) | 2006-04-18 | 2014-08-19 | Advanced Liquid Logic, Inc. | Manipulation of beads in droplets and methods for manipulating droplets |
WO2007123908A2 (en) * | 2006-04-18 | 2007-11-01 | Advanced Liquid Logic, Inc. | Droplet-based multiwell operations |
US10078078B2 (en) | 2006-04-18 | 2018-09-18 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
US8637324B2 (en) | 2006-04-18 | 2014-01-28 | Advanced Liquid Logic, Inc. | Bead incubation and washing on a droplet actuator |
US7439014B2 (en) | 2006-04-18 | 2008-10-21 | Advanced Liquid Logic, Inc. | Droplet-based surface modification and washing |
US8716015B2 (en) | 2006-04-18 | 2014-05-06 | Advanced Liquid Logic, Inc. | Manipulation of cells on a droplet actuator |
US7763471B2 (en) | 2006-04-18 | 2010-07-27 | Advanced Liquid Logic, Inc. | Method of electrowetting droplet operations for protein crystallization |
US7851184B2 (en) | 2006-04-18 | 2010-12-14 | Advanced Liquid Logic, Inc. | Droplet-based nucleic acid amplification method and apparatus |
US7822510B2 (en) | 2006-05-09 | 2010-10-26 | Advanced Liquid Logic, Inc. | Systems, methods, and products for graphically illustrating and controlling a droplet actuator |
US8041463B2 (en) * | 2006-05-09 | 2011-10-18 | Advanced Liquid Logic, Inc. | Modular droplet actuator drive |
US7939021B2 (en) | 2007-05-09 | 2011-05-10 | Advanced Liquid Logic, Inc. | Droplet actuator analyzer with cartridge |
US9074242B2 (en) | 2010-02-12 | 2015-07-07 | Raindance Technologies, Inc. | Digital analyte analysis |
EP2530168B1 (en) | 2006-05-11 | 2015-09-16 | Raindance Technologies, Inc. | Microfluidic Devices |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
US7629124B2 (en) | 2006-06-30 | 2009-12-08 | Canon U.S. Life Sciences, Inc. | Real-time PCR in micro-channels |
WO2008061165A2 (en) | 2006-11-14 | 2008-05-22 | Handylab, Inc. | Microfluidic cartridge and method of making same |
US20080145898A1 (en) * | 2006-12-14 | 2008-06-19 | Applera Corporation | Sequencing methods |
US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
WO2008109176A2 (en) | 2007-03-07 | 2008-09-12 | President And Fellows Of Harvard College | Assays and other reactions involving droplets |
AU2008236691B2 (en) | 2007-04-04 | 2014-08-07 | Ande Corporation | Integrated nucleic acid analysis |
US8592221B2 (en) | 2007-04-19 | 2013-11-26 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US8105783B2 (en) | 2007-07-13 | 2012-01-31 | Handylab, Inc. | Microfluidic cartridge |
US8287820B2 (en) | 2007-07-13 | 2012-10-16 | Handylab, Inc. | Automated pipetting apparatus having a combined liquid pump and pipette head system |
US8133671B2 (en) | 2007-07-13 | 2012-03-13 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
US9186677B2 (en) | 2007-07-13 | 2015-11-17 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
US8182763B2 (en) | 2007-07-13 | 2012-05-22 | Handylab, Inc. | Rack for sample tubes and reagent holders |
WO2009012185A1 (en) | 2007-07-13 | 2009-01-22 | Handylab, Inc. | Polynucleotide capture materials, and methods of using same |
US9618139B2 (en) | 2007-07-13 | 2017-04-11 | Handylab, Inc. | Integrated heater and magnetic separator |
US8268246B2 (en) | 2007-08-09 | 2012-09-18 | Advanced Liquid Logic Inc | PCB droplet actuator fabrication |
WO2009021215A1 (en) * | 2007-08-09 | 2009-02-12 | Celula, Inc. | Methods and devices for correlated, multi-parameter single cell measurements and recovery of remnant biological material |
JP5052996B2 (en) * | 2007-08-22 | 2012-10-17 | アイダエンジニアリング株式会社 | Microchannel chip for electrophoresis and electrophoresis method |
CN101946010B (en) | 2007-12-21 | 2014-08-20 | 哈佛大学 | Systems and methods for nucleic acid sequencing |
US8815576B2 (en) * | 2007-12-27 | 2014-08-26 | Lawrence Livermore National Security, Llc. | Chip-based sequencing nucleic acids |
USD787087S1 (en) | 2008-07-14 | 2017-05-16 | Handylab, Inc. | Housing |
EP4047367A1 (en) | 2008-07-18 | 2022-08-24 | Bio-Rad Laboratories, Inc. | Method for detecting target analytes with droplet libraries |
WO2010033200A2 (en) | 2008-09-19 | 2010-03-25 | President And Fellows Of Harvard College | Creation of libraries of droplets and related species |
WO2010080134A1 (en) | 2008-12-19 | 2010-07-15 | President And Fellows Of Harvard College | Particle-assisted nucleic acid sequencing |
KR20120031218A (en) | 2009-06-05 | 2012-03-30 | 인터젠엑스 인크. | Universal sample preparation system and use in an integrated analysis system |
JP2012529908A (en) | 2009-06-15 | 2012-11-29 | ネットバイオ・インコーポレーテッド | Improved method for quantification of forensic DNA |
US8492165B2 (en) * | 2009-09-01 | 2013-07-23 | Corsolutions, Llc | Microfluidic interface |
AU2010315580B2 (en) | 2009-10-27 | 2014-11-06 | President And Fellows Of Harvard College | Droplet creation techniques |
US9500645B2 (en) | 2009-11-23 | 2016-11-22 | Cyvek, Inc. | Micro-tube particles for microfluidic assays and methods of manufacture |
US9759718B2 (en) | 2009-11-23 | 2017-09-12 | Cyvek, Inc. | PDMS membrane-confined nucleic acid and antibody/antigen-functionalized microlength tube capture elements, and systems employing them, and methods of their use |
CA2781556C (en) | 2009-11-23 | 2015-05-19 | Cyvek, Inc. | Method and apparatus for performing assays |
US10065403B2 (en) | 2009-11-23 | 2018-09-04 | Cyvek, Inc. | Microfluidic assay assemblies and methods of manufacture |
US10022696B2 (en) | 2009-11-23 | 2018-07-17 | Cyvek, Inc. | Microfluidic assay systems employing micro-particles and methods of manufacture |
US9700889B2 (en) | 2009-11-23 | 2017-07-11 | Cyvek, Inc. | Methods and systems for manufacture of microarray assay systems, conducting microfluidic assays, and monitoring and scanning to obtain microfluidic assay results |
US9855735B2 (en) | 2009-11-23 | 2018-01-02 | Cyvek, Inc. | Portable microfluidic assay devices and methods of manufacture and use |
WO2013134745A1 (en) | 2012-03-08 | 2013-09-12 | Cyvek, Inc | Portable microfluidic assay devices and methods of manufacture and use |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US8530158B2 (en) | 2010-05-10 | 2013-09-10 | Life Technologies Corporation | System and method for processing a biological sample |
WO2012045012A2 (en) | 2010-09-30 | 2012-04-05 | Raindance Technologies, Inc. | Sandwich assays in droplets |
EP3412778A1 (en) | 2011-02-11 | 2018-12-12 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
WO2012112804A1 (en) | 2011-02-18 | 2012-08-23 | Raindance Technoligies, Inc. | Compositions and methods for molecular labeling |
US10254204B2 (en) | 2011-03-07 | 2019-04-09 | Accelerate Diagnostics, Inc. | Membrane-assisted purification |
ES2551922T3 (en) | 2011-03-07 | 2015-11-24 | Accelerate Diagnostics, Inc. | Rapid cell purification systems |
CN106552682B (en) | 2011-03-22 | 2020-06-19 | 西维克公司 | Microfluidic device and methods of manufacture and use |
BR112013026451B1 (en) | 2011-04-15 | 2021-02-09 | Becton, Dickinson And Company | system and method to perform molecular diagnostic tests on several samples in parallel and simultaneously amplification in real time in plurality of amplification reaction chambers |
WO2012167142A2 (en) | 2011-06-02 | 2012-12-06 | Raindance Technolgies, Inc. | Enzyme quantification |
WO2012170562A2 (en) | 2011-06-06 | 2012-12-13 | Corsolutions, Llc | Fluidic interface |
US9513253B2 (en) | 2011-07-11 | 2016-12-06 | Advanced Liquid Logic, Inc. | Droplet actuators and techniques for droplet-based enzymatic assays |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
US8975193B2 (en) | 2011-08-02 | 2015-03-10 | Teledyne Dalsa Semiconductor, Inc. | Method of making a microfluidic device |
USD692162S1 (en) | 2011-09-30 | 2013-10-22 | Becton, Dickinson And Company | Single piece reagent holder |
EP2761305B1 (en) | 2011-09-30 | 2017-08-16 | Becton, Dickinson and Company | Unitized reagent strip |
US10865440B2 (en) | 2011-10-21 | 2020-12-15 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
US20150136604A1 (en) | 2011-10-21 | 2015-05-21 | Integenx Inc. | Sample preparation, processing and analysis systems |
EP2773892B1 (en) | 2011-11-04 | 2020-10-07 | Handylab, Inc. | Polynucleotide sample preparation device |
US9366669B2 (en) * | 2011-12-20 | 2016-06-14 | Siemens Healthcare Diagnostics Inc. | Coated substrates for high energy capture phase binding and methods of production and use thereof |
EP2872523B1 (en) | 2011-12-30 | 2018-01-17 | Abbott Molecular Inc. | Microorganism nucleic acid purification from host samples |
AU2013214849B2 (en) | 2012-02-03 | 2016-09-01 | Becton, Dickinson And Company | External files for distribution of molecular diagnostic tests and determination of compatibility between tests |
KR101398956B1 (en) * | 2012-05-23 | 2014-05-27 | 가천대학교 산학협력단 | Nucleic acids amplifying device, preparing method for the same and amplification method nucleic acids using the same |
US10273541B2 (en) | 2012-08-14 | 2019-04-30 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US11591637B2 (en) | 2012-08-14 | 2023-02-28 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US9388465B2 (en) | 2013-02-08 | 2016-07-12 | 10X Genomics, Inc. | Polynucleotide barcode generation |
US10323279B2 (en) | 2012-08-14 | 2019-06-18 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9567631B2 (en) | 2012-12-14 | 2017-02-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9701998B2 (en) | 2012-12-14 | 2017-07-11 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
CA2881685C (en) | 2012-08-14 | 2023-12-05 | 10X Genomics, Inc. | Microcapsule compositions and methods |
US9951386B2 (en) | 2014-06-26 | 2018-04-24 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10584381B2 (en) | 2012-08-14 | 2020-03-10 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10752949B2 (en) | 2012-08-14 | 2020-08-25 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10221442B2 (en) | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
US10533221B2 (en) | 2012-12-14 | 2020-01-14 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US9677109B2 (en) | 2013-03-15 | 2017-06-13 | Accelerate Diagnostics, Inc. | Rapid determination of microbial growth and antimicrobial susceptibility |
US10071374B2 (en) * | 2013-08-05 | 2018-09-11 | Waters Technologies Corporation | Apparatus and methods for creating a static and traversing thermal gradient on a microfluidic device |
US10395758B2 (en) | 2013-08-30 | 2019-08-27 | 10X Genomics, Inc. | Sequencing methods |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
WO2015069798A1 (en) * | 2013-11-05 | 2015-05-14 | The Regents Of The University Of California | Single-cell forensic short tandem repeat typing within microfluidic droplets |
US20160279068A1 (en) | 2013-11-08 | 2016-09-29 | President And Fellows Of Harvard College | Microparticles, methods for their preparation and use |
CN110560187B (en) | 2013-11-18 | 2022-01-11 | 尹特根埃克斯有限公司 | Cartridge and instrument for sample analysis |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US9824068B2 (en) | 2013-12-16 | 2017-11-21 | 10X Genomics, Inc. | Methods and apparatus for sorting data |
WO2015112914A1 (en) | 2014-01-24 | 2015-07-30 | Life Technologies Corporation | Purification chemistries and formats for sanger dna sequencing reactions on a micro-fluidics device |
AU2015243445B2 (en) | 2014-04-10 | 2020-05-28 | 10X Genomics, Inc. | Fluidic devices, systems, and methods for encapsulating and partitioning reagents, and applications of same |
WO2015179098A1 (en) | 2014-05-21 | 2015-11-26 | Integenx Inc. | Fluidic cartridge with valve mechanism |
KR20170023979A (en) | 2014-06-26 | 2017-03-06 | 10엑스 제노믹스, 인크. | Processes and systems for nucleic acid sequence assembly |
EP4053292A1 (en) | 2014-06-26 | 2022-09-07 | 10X Genomics, Inc. | Methods of analyzing nucleic acids from individual cells or cell populations |
EP3552690A1 (en) | 2014-10-22 | 2019-10-16 | IntegenX Inc. | Systems and methods for sample preparation, processing and analysis |
WO2016069939A1 (en) | 2014-10-29 | 2016-05-06 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
US9975122B2 (en) | 2014-11-05 | 2018-05-22 | 10X Genomics, Inc. | Instrument systems for integrated sample processing |
CA2972969A1 (en) | 2015-01-12 | 2016-07-21 | 10X Genomics, Inc. | Processes and systems for preparing nucleic acid sequencing libraries and libraries prepared using same |
EP3245605B1 (en) | 2015-01-13 | 2022-04-20 | 10X Genomics, Inc. | Systems and methods for visualizing structural variation and phasing information |
WO2016130578A1 (en) | 2015-02-09 | 2016-08-18 | 10X Genomics, Inc. | Systems and methods for determining structural variation and phasing using variant call data |
WO2016138148A1 (en) | 2015-02-24 | 2016-09-01 | 10X Genomics, Inc. | Methods for targeted nucleic acid sequence coverage |
EP3262407B1 (en) | 2015-02-24 | 2023-08-30 | 10X Genomics, Inc. | Partition processing methods and systems |
US10253355B2 (en) | 2015-03-30 | 2019-04-09 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing |
US10023895B2 (en) * | 2015-03-30 | 2018-07-17 | Accelerate Diagnostics, Inc. | Instrument and system for rapid microogranism identification and antimicrobial agent susceptibility testing |
US10233491B2 (en) | 2015-06-19 | 2019-03-19 | IntegenX, Inc. | Valved cartridge and system |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
US11123297B2 (en) | 2015-10-13 | 2021-09-21 | President And Fellows Of Harvard College | Systems and methods for making and using gel microspheres |
US10376885B2 (en) | 2015-11-04 | 2019-08-13 | Lehigh University | Microfluidic concentrator for label-free, continuous nanoparticle processing |
US11371094B2 (en) | 2015-11-19 | 2022-06-28 | 10X Genomics, Inc. | Systems and methods for nucleic acid processing using degenerate nucleotides |
US10228367B2 (en) | 2015-12-01 | 2019-03-12 | ProteinSimple | Segmented multi-use automated assay cartridge |
CN115369161A (en) | 2015-12-04 | 2022-11-22 | 10X 基因组学有限公司 | Methods and compositions for nucleic acid analysis |
JP6735348B2 (en) | 2016-02-11 | 2020-08-05 | 10エックス ジェノミクス, インコーポレイテッド | Systems, methods and media for de novo assembly of whole genome sequence data |
WO2017197338A1 (en) | 2016-05-13 | 2017-11-16 | 10X Genomics, Inc. | Microfluidic systems and methods of use |
US10815525B2 (en) | 2016-12-22 | 2020-10-27 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
US10011872B1 (en) | 2016-12-22 | 2018-07-03 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
EP3558524A1 (en) * | 2016-12-22 | 2019-10-30 | IMEC vzw | A microfluidic device for sorting out droplets |
US10550429B2 (en) | 2016-12-22 | 2020-02-04 | 10X Genomics, Inc. | Methods and systems for processing polynucleotides |
EP4029939B1 (en) | 2017-01-30 | 2023-06-28 | 10X Genomics, Inc. | Methods and systems for droplet-based single cell barcoding |
US10995333B2 (en) | 2017-02-06 | 2021-05-04 | 10X Genomics, Inc. | Systems and methods for nucleic acid preparation |
EP3625715A4 (en) | 2017-05-19 | 2021-03-17 | 10X Genomics, Inc. | Systems and methods for analyzing datasets |
SG11201901822QA (en) | 2017-05-26 | 2019-03-28 | 10X Genomics Inc | Single cell analysis of transposase accessible chromatin |
US20180340169A1 (en) | 2017-05-26 | 2018-11-29 | 10X Genomics, Inc. | Single cell analysis of transposase accessible chromatin |
US10837047B2 (en) | 2017-10-04 | 2020-11-17 | 10X Genomics, Inc. | Compositions, methods, and systems for bead formation using improved polymers |
WO2019084043A1 (en) | 2017-10-26 | 2019-05-02 | 10X Genomics, Inc. | Methods and systems for nuclecic acid preparation and chromatin analysis |
CN114525273A (en) | 2017-10-27 | 2022-05-24 | 10X基因组学有限公司 | Methods and systems for sample preparation and analysis |
SG11201913654QA (en) | 2017-11-15 | 2020-01-30 | 10X Genomics Inc | Functionalized gel beads |
US10829815B2 (en) | 2017-11-17 | 2020-11-10 | 10X Genomics, Inc. | Methods and systems for associating physical and genetic properties of biological particles |
WO2019108851A1 (en) | 2017-11-30 | 2019-06-06 | 10X Genomics, Inc. | Systems and methods for nucleic acid preparation and analysis |
WO2019157529A1 (en) | 2018-02-12 | 2019-08-15 | 10X Genomics, Inc. | Methods characterizing multiple analytes from individual cells or cell populations |
US11639928B2 (en) | 2018-02-22 | 2023-05-02 | 10X Genomics, Inc. | Methods and systems for characterizing analytes from individual cells or cell populations |
EP3775271A1 (en) | 2018-04-06 | 2021-02-17 | 10X Genomics, Inc. | Systems and methods for quality control in single cell processing |
US11932899B2 (en) | 2018-06-07 | 2024-03-19 | 10X Genomics, Inc. | Methods and systems for characterizing nucleic acid molecules |
US11703427B2 (en) | 2018-06-25 | 2023-07-18 | 10X Genomics, Inc. | Methods and systems for cell and bead processing |
US20200032335A1 (en) | 2018-07-27 | 2020-01-30 | 10X Genomics, Inc. | Systems and methods for metabolome analysis |
US11459607B1 (en) | 2018-12-10 | 2022-10-04 | 10X Genomics, Inc. | Systems and methods for processing-nucleic acid molecules from a single cell using sequential co-partitioning and composite barcodes |
US11845983B1 (en) | 2019-01-09 | 2023-12-19 | 10X Genomics, Inc. | Methods and systems for multiplexing of droplet based assays |
US11851683B1 (en) | 2019-02-12 | 2023-12-26 | 10X Genomics, Inc. | Methods and systems for selective analysis of cellular samples |
US11467153B2 (en) | 2019-02-12 | 2022-10-11 | 10X Genomics, Inc. | Methods for processing nucleic acid molecules |
SG11202108788TA (en) | 2019-02-12 | 2021-09-29 | 10X Genomics Inc | Methods for processing nucleic acid molecules |
US11655499B1 (en) | 2019-02-25 | 2023-05-23 | 10X Genomics, Inc. | Detection of sequence elements in nucleic acid molecules |
CN113767178A (en) | 2019-03-11 | 2021-12-07 | 10X基因组学有限公司 | Systems and methods for processing optically labeled beads |
US11851700B1 (en) | 2020-05-13 | 2023-12-26 | 10X Genomics, Inc. | Methods, kits, and compositions for processing extracellular molecules |
EP4298244A1 (en) | 2021-02-23 | 2024-01-03 | 10X Genomics, Inc. | Probe-based analysis of nucleic acids and proteins |
Citations (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US600775A (en) * | 1898-03-15 | Punching-bag platform | ||
US3190310A (en) * | 1960-12-16 | 1965-06-22 | American Radiator & Standard | Gang valve arrangement |
US3433257A (en) * | 1966-02-01 | 1969-03-18 | Ibm | Diaphragm type fluid logic latch |
US3568692A (en) * | 1967-11-27 | 1971-03-09 | Bowles Eng Corp | Optical machining process |
US5635358A (en) * | 1992-05-01 | 1997-06-03 | Trustees Of The University Of Pennsylvania | Fluid handling methods for use in mesoscale analytical devices |
US5639428A (en) * | 1994-07-19 | 1997-06-17 | Becton Dickinson And Company | Method and apparatus for fully automated nucleic acid amplification, nucleic acid assay and immunoassay |
US5705813A (en) * | 1995-11-01 | 1998-01-06 | Hewlett-Packard Company | Integrated planar liquid handling system for maldi-TOF MS |
US5726026A (en) * | 1992-05-01 | 1998-03-10 | Trustees Of The University Of Pennsylvania | Mesoscale sample preparation device and systems for determination and processing of analytes |
US5741462A (en) * | 1995-04-25 | 1998-04-21 | Irori | Remotely programmable matrices with memories |
US5750015A (en) * | 1990-02-28 | 1998-05-12 | Soane Biosciences | Method and device for moving molecules by the application of a plurality of electrical fields |
US5770029A (en) * | 1996-07-30 | 1998-06-23 | Soane Biosciences | Integrated electrophoretic microdevices |
US5856174A (en) * | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US5863502A (en) * | 1996-01-24 | 1999-01-26 | Sarnoff Corporation | Parallel reaction cassette and associated devices |
US5885470A (en) * | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
US5900130A (en) * | 1997-06-18 | 1999-05-04 | Alcara Biosciences, Inc. | Method for sample injection in microchannel device |
US5908552A (en) * | 1995-12-14 | 1999-06-01 | Hewlett-Packard Company | Column for capillary chromatographic separations |
US6010607A (en) * | 1994-08-01 | 2000-01-04 | Lockheed Martin Energy Research Corporation | Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
US6027031A (en) * | 1997-12-19 | 2000-02-22 | Carrier Corporation | Method and apparatus for changing operational modes of a transport refrigeration system |
US6048100A (en) * | 1999-03-10 | 2000-04-11 | Industrial Label Corp. | Resealable closure for a bag |
US6056860A (en) * | 1996-09-18 | 2000-05-02 | Aclara Biosciences, Inc. | Surface modified electrophoretic chambers |
US6074827A (en) * | 1996-07-30 | 2000-06-13 | Aclara Biosciences, Inc. | Microfluidic method for nucleic acid purification and processing |
US6073482A (en) * | 1997-07-21 | 2000-06-13 | Ysi Incorporated | Fluid flow module |
US6168948B1 (en) * | 1995-06-29 | 2001-01-02 | Affymetrix, Inc. | Miniaturized genetic analysis systems and methods |
US6179962B1 (en) * | 1997-12-31 | 2001-01-30 | Hercules Incorporated | Paper having improved strength characteristics and process for making same |
US6190616B1 (en) * | 1997-09-11 | 2001-02-20 | Molecular Dynamics, Inc. | Capillary valve, connector, and router |
US6235471B1 (en) * | 1997-04-04 | 2001-05-22 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
US6251343B1 (en) * | 1998-02-24 | 2001-06-26 | Caliper Technologies Corp. | Microfluidic devices and systems incorporating cover layers |
US6348318B1 (en) * | 1997-04-04 | 2002-02-19 | Biosite Diagnostics | Methods for concentrating ligands using magnetic particles |
US20020022587A1 (en) * | 2000-03-28 | 2002-02-21 | Ferguson Alastair V. | Methods for effecting neuroprotection |
US20020025576A1 (en) * | 1998-03-17 | 2002-02-28 | Cepheid | Integrated sample analysis device |
US20020025529A1 (en) * | 1999-06-28 | 2002-02-28 | Stephen Quake | Methods and apparatus for analyzing polynucleotide sequences |
US20020048536A1 (en) * | 1999-03-03 | 2002-04-25 | Bergh H. Sam | Parallel flow process optimization reactors |
US20020047003A1 (en) * | 2000-06-28 | 2002-04-25 | William Bedingham | Enhanced sample processing devices, systems and methods |
US6379929B1 (en) * | 1996-11-20 | 2002-04-30 | The Regents Of The University Of Michigan | Chip-based isothermal amplification devices and methods |
US20020051992A1 (en) * | 1997-05-23 | 2002-05-02 | Lynx Therapeutics, Inc. | System and apparatus for sequential processing of analytes |
US20020058332A1 (en) * | 2000-09-15 | 2002-05-16 | California Institute Of Technology | Microfabricated crossflow devices and methods |
US20020068357A1 (en) * | 1995-09-28 | 2002-06-06 | Mathies Richard A. | Miniaturized integrated nucleic acid processing and analysis device and method |
US20030008308A1 (en) * | 2001-04-06 | 2003-01-09 | California Institute Of Technology | Nucleic acid amplification utilizing microfluidic devices |
US20030021734A1 (en) * | 1999-02-16 | 2003-01-30 | Vann Charles S. | Bead dispensing system |
US6521188B1 (en) * | 2000-11-22 | 2003-02-18 | Industrial Technology Research Institute | Microfluidic actuator |
US6524456B1 (en) * | 1999-08-12 | 2003-02-25 | Ut-Battelle, Llc | Microfluidic devices for the controlled manipulation of small volumes |
US6532997B1 (en) * | 2001-12-28 | 2003-03-18 | 3M Innovative Properties Company | Sample processing device with integral electrophoresis channels |
US6533914B1 (en) * | 1999-07-08 | 2003-03-18 | Shaorong Liu | Microfabricated injector and capillary array assembly for high-resolution and high throughput separation |
US6537757B1 (en) * | 1997-03-05 | 2003-03-25 | The Regents Of The University Of Michigan | Nucleic acid sequencing and mapping |
US6544734B1 (en) * | 1998-10-09 | 2003-04-08 | Cynthia G. Briscoe | Multilayered microfluidic DNA analysis system and method |
US20030070677A1 (en) * | 2000-07-24 | 2003-04-17 | The Regents Of The University Of Michigan | Compositions and methods for liquid metering in microchannels |
US20040014091A1 (en) * | 2002-03-11 | 2004-01-22 | Athenix Corporation | Integrated system for high throughput capture of genetic diversity |
USD486156S1 (en) * | 2001-06-27 | 2004-02-03 | Fluidigm Corporation | Fluidic taper icon for a display screen |
US6685442B2 (en) * | 2002-02-20 | 2004-02-03 | Sandia National Laboratories | Actuator device utilizing a conductive polymer gel |
US20040037739A1 (en) * | 2001-03-09 | 2004-02-26 | Mcneely Michael | Method and system for microfluidic interfacing to arrays |
US20040038385A1 (en) * | 2002-08-26 | 2004-02-26 | Langlois Richard G. | System for autonomous monitoring of bioagents |
US6705345B1 (en) * | 1999-11-08 | 2004-03-16 | The Trustees Of Boston University | Micro valve arrays for fluid flow control |
US20040053290A1 (en) * | 2000-01-11 | 2004-03-18 | Terbrueggen Robert Henry | Devices and methods for biochip multiplexing |
US20040063217A1 (en) * | 2002-09-27 | 2004-04-01 | Webster James Russell | Miniaturized fluid delivery and analysis system |
US20040072278A1 (en) * | 2002-04-01 | 2004-04-15 | Fluidigm Corporation | Microfluidic particle-analysis systems |
USD488818S1 (en) * | 2001-06-27 | 2004-04-20 | Fluidigm Corporation | Fluidic rotary mixer square icon for a display screen |
US20040086872A1 (en) * | 2002-10-31 | 2004-05-06 | Childers Winthrop D. | Microfluidic system for analysis of nucleic acids |
US6853287B1 (en) * | 2001-03-30 | 2005-02-08 | Intel Corporation | Coil for use on a substrate |
US20050047967A1 (en) * | 2003-09-03 | 2005-03-03 | Industrial Technology Research Institute | Microfluidic component providing multi-directional fluid movement |
US20050053952A1 (en) * | 2002-10-02 | 2005-03-10 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US6870185B2 (en) * | 2002-08-02 | 2005-03-22 | Amersham Biosciences (Sv) Corp | Integrated microchip design |
US6885982B2 (en) * | 2000-06-27 | 2005-04-26 | Fluidigm Corporation | Object oriented microfluidic design method and system |
US6899137B2 (en) * | 1999-06-28 | 2005-05-31 | California Institute Of Technology | Microfabricated elastomeric valve and pump systems |
US20060027456A1 (en) * | 2002-05-24 | 2006-02-09 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
US7005292B2 (en) * | 1992-05-01 | 2006-02-28 | The Trustees Of The University Of Pennsylvania | Device and method for the detection of an analyte utilizing mesoscale flow systems |
US7005493B2 (en) * | 2001-04-06 | 2006-02-28 | Fluidigm Corporation | Polymer surface modification |
US20060057209A1 (en) * | 2004-09-16 | 2006-03-16 | Predicant Biosciences, Inc. | Methods, compositions and devices, including microfluidic devices, comprising coated hydrophobic surfaces |
US7015030B1 (en) * | 1999-07-28 | 2006-03-21 | Genset S.A. | Microfluidic devices and uses thereof in biochemical processes |
US20060073484A1 (en) * | 2002-12-30 | 2006-04-06 | Mathies Richard A | Methods and apparatus for pathogen detection and analysis |
US20060076068A1 (en) * | 2004-10-13 | 2006-04-13 | Kionix Corporation | Microfluidic pump and valve structures and fabrication methods |
US7046357B2 (en) * | 2003-01-30 | 2006-05-16 | Ciphergen Biosystems, Inc. | Apparatus for microfluidic processing and reading of biochip arrays |
US20070017812A1 (en) * | 2005-03-30 | 2007-01-25 | Luc Bousse | Optimized Sample Injection Structures in Microfluidic Separations |
US20070034025A1 (en) * | 2005-08-09 | 2007-02-15 | Cfd Research Corporation | Electrostatic sampler and method |
US7198759B2 (en) * | 2002-07-26 | 2007-04-03 | Applera Corporation | Microfluidic devices, methods, and systems |
US20070105163A1 (en) * | 2001-08-31 | 2007-05-10 | Grate Jay W | Flow-controlled magnetic particle manipulation |
US20070122819A1 (en) * | 2005-11-25 | 2007-05-31 | Industrial Technology Research Institute | Analyte assay structure in microfluidic chip for quantitative analysis and method for using the same |
US20080014589A1 (en) * | 2006-05-11 | 2008-01-17 | Link Darren R | Microfluidic devices and methods of use thereof |
US20080014576A1 (en) * | 2006-02-03 | 2008-01-17 | Microchip Biotechnologies, Inc. | Microfluidic devices |
US7323305B2 (en) * | 2003-01-29 | 2008-01-29 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
US20080047836A1 (en) * | 2002-12-05 | 2008-02-28 | David Strand | Configurable Microfluidic Substrate Assembly |
US20080124723A1 (en) * | 2006-06-30 | 2008-05-29 | Canon U.S. Life Sciences, Inc. | Combined thermal devices for thermal cycling |
US20090004494A1 (en) * | 2000-12-29 | 2009-01-01 | Kimberly-Clark Worldwide, Inc. | Laminated absorbent product with increased strength in defined areas |
US20090035770A1 (en) * | 2006-10-25 | 2009-02-05 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
US7488603B2 (en) * | 2003-07-14 | 2009-02-10 | Phynexus, Inc. | Method and device for extracting an analyte |
US20090053799A1 (en) * | 2007-08-23 | 2009-02-26 | Cynvenio Biosystems, Llc | Trapping magnetic sorting system for target species |
US20090137413A1 (en) * | 1999-02-23 | 2009-05-28 | Caliper Life Sciences, Inc. | Manipulation of Microparticles In Microfluidic Systems |
US20090134069A1 (en) * | 2007-07-13 | 2009-05-28 | Handylab, Inc. | Integrated Heater and Magnetic Separator |
US20100068723A1 (en) * | 2004-09-15 | 2010-03-18 | Stevan Bogdan Jovanovich | Microfluidic devices |
US20110005932A1 (en) * | 2009-06-05 | 2011-01-13 | Integenx Inc. | Universal sample preparation system and use in an integrated analysis system |
US20110027913A1 (en) * | 2007-02-06 | 2011-02-03 | Bau Haim H | Multiplexed nanoscale electrochemical sensors for multi-analyte detection |
US20110039303A1 (en) * | 2007-02-05 | 2011-02-17 | Stevan Bogdan Jovanovich | Microfluidic and nanofluidic devices, systems, and applications |
US20110048945A1 (en) * | 1999-11-26 | 2011-03-03 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
Family Cites Families (128)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3352643A (en) | 1964-09-02 | 1967-11-14 | Hitachi Ltd | Liquid chromatography and chromatographs |
US3636334A (en) | 1969-01-02 | 1972-01-18 | Univ California | Parallel adder with distributed control to add a plurality of binary numbers |
US3610274A (en) | 1969-10-08 | 1971-10-05 | Brown & Sharpe Mfg | Fluid logic circuit |
CH539210A (en) | 1970-05-26 | 1973-07-15 | Ondrej Brychta Und Christopher | Logical fluidic circuit |
US4495210A (en) | 1980-05-28 | 1985-01-22 | Societe D'assistance Technique Pour Produits Nestle S.A. | Caffeine adsorption |
US4304257A (en) | 1980-07-01 | 1981-12-08 | Instrumentation Laboratory Inc. | Valve with flexible sheet member |
US4357675A (en) | 1980-08-04 | 1982-11-02 | Bell Telephone Laboratories, Incorporated | Ripple-carry generating circuit with carry regeneration |
GB2094731B (en) | 1981-03-12 | 1983-09-07 | Surrey Steel Components Ltd | Adjustable rear view mirrors |
US4703913A (en) | 1982-09-22 | 1987-11-03 | California Institute Of Technology | Diaphragm valve |
US4558845A (en) | 1982-09-22 | 1985-12-17 | Hunkapiller Michael W | Zero dead volume valve |
US4963498A (en) | 1985-08-05 | 1990-10-16 | Biotrack | Capillary flow device |
US6176962B1 (en) * | 1990-02-28 | 2001-01-23 | Aclara Biosciences, Inc. | Methods for fabricating enclosed microchannel structures |
SE470347B (en) | 1990-05-10 | 1994-01-31 | Pharmacia Lkb Biotech | Microstructure for fluid flow systems and process for manufacturing such a system |
EP0459241B1 (en) | 1990-05-29 | 1994-10-26 | Waters Investments Limited | Process and apparatus for effecting capillary electrophoresis |
NL9001500A (en) | 1990-07-02 | 1992-02-03 | Philips Nv | INTEGRATED CIRCUIT FITTED WITH AN INPUT BUFFER CIRCUIT. |
ATE174813T1 (en) | 1992-05-01 | 1999-01-15 | Univ Pennsylvania | POLYNUCLEOTIDE AMPLIFICATION ANALYSIS USING A MICROFABRICATED DEVICE |
US5587128A (en) * | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
EP1296134B1 (en) * | 1993-04-15 | 2013-05-29 | Bayer Intellectual Property GmbH | Sampling device and its use for controlling sample introduction in microcolumn separation techniques |
US5453163A (en) * | 1993-10-29 | 1995-09-26 | Yan; Chao | Electrokinetic packing of capillary columns |
US6129828A (en) | 1996-09-06 | 2000-10-10 | Nanogen, Inc. | Apparatus and methods for active biological sample preparation |
US5609919A (en) | 1994-04-21 | 1997-03-11 | Altamat Inc. | Method for producing droplets |
US5571410A (en) | 1994-10-19 | 1996-11-05 | Hewlett Packard Company | Fully integrated miniaturized planar liquid sample handling and analysis device |
US5775371A (en) * | 1995-03-08 | 1998-07-07 | Abbott Laboratories | Valve control |
US5942443A (en) * | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
DE69728269T2 (en) * | 1996-06-14 | 2005-03-10 | University Of Washington, Seattle | ABSORBENT IMPROVED DIFFERENTIAL EXTRACTION PROCESS |
NZ333346A (en) | 1996-06-28 | 2000-03-27 | Caliper Techn Corp | High-throughput screening assay systems in microscale fluidic devices |
US6136212A (en) * | 1996-08-12 | 2000-10-24 | The Regents Of The University Of Michigan | Polymer-based micromachining for microfluidic devices |
EP0981408B1 (en) | 1997-05-16 | 2004-04-21 | Alberta Research Council | Microfluidic system and methods of use |
US6632619B1 (en) * | 1997-05-16 | 2003-10-14 | The Governors Of The University Of Alberta | Microfluidic system and methods of use |
WO1999014368A2 (en) | 1997-09-15 | 1999-03-25 | Whitehead Institute For Biomedical Research | Methods and apparatus for processing a sample of biomolecular analyte using a microfabricated device |
US6007775A (en) | 1997-09-26 | 1999-12-28 | University Of Washington | Multiple analyte diffusion based chemical sensor |
US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
US6803019B1 (en) | 1997-10-15 | 2004-10-12 | Aclara Biosciences, Inc. | Laminate microstructure device and method for making same |
US6120985A (en) | 1997-10-31 | 2000-09-19 | Bbi Bioseq, Inc. | Pressure-enhanced extraction and purification |
US6167910B1 (en) | 1998-01-20 | 2001-01-02 | Caliper Technologies Corp. | Multi-layer microfluidic devices |
US6200814B1 (en) | 1998-01-20 | 2001-03-13 | Biacore Ab | Method and device for laminar flow on a sensing surface |
US6663833B1 (en) | 1998-03-10 | 2003-12-16 | Strategic Diagnostics Inc. | Integrated assay device and methods of production and use |
US6787111B2 (en) * | 1998-07-02 | 2004-09-07 | Amersham Biosciences (Sv) Corp. | Apparatus and method for filling and cleaning channels and inlet ports in microchips used for biological analysis |
US6627446B1 (en) * | 1998-07-02 | 2003-09-30 | Amersham Biosciences (Sv) Corp | Robotic microchannel bioanalytical instrument |
US6103199A (en) * | 1998-09-15 | 2000-08-15 | Aclara Biosciences, Inc. | Capillary electroflow apparatus and method |
GB9900298D0 (en) * | 1999-01-07 | 1999-02-24 | Medical Res Council | Optical sorting method |
EP1411340A3 (en) | 1999-02-26 | 2004-05-19 | EXACT Sciences Corporation | Biochemical purification devices with immobilized capture probes and their uses |
AU772213C (en) * | 1999-02-26 | 2004-12-09 | Exact Sciences Corporation | Biochemical purification devices with immobilized capture probes and their uses |
US6319476B1 (en) | 1999-03-02 | 2001-11-20 | Perseptive Biosystems, Inc. | Microfluidic connector |
WO2000060362A1 (en) | 1999-04-08 | 2000-10-12 | Chung Chang Young | Apparatus for fast preparation and analysis of nucleic acids |
JP3746658B2 (en) * | 1999-04-12 | 2006-02-15 | 株式会社日立製作所 | Method and apparatus for producing probe array using fine particles |
US6322683B1 (en) | 1999-04-14 | 2001-11-27 | Caliper Technologies Corp. | Alignment of multicomponent microfabricated structures |
US6520753B1 (en) | 1999-06-04 | 2003-02-18 | California Institute Of Technology | Planar micropump |
IL147302A0 (en) * | 1999-06-28 | 2002-08-14 | California Inst Of Techn | Microfabricated elastomeric valve and pump systems |
US6929030B2 (en) * | 1999-06-28 | 2005-08-16 | California Institute Of Technology | Microfabricated elastomeric valve and pump systems |
US6977145B2 (en) | 1999-07-28 | 2005-12-20 | Serono Genetics Institute S.A. | Method for carrying out a biochemical protocol in continuous flow in a microreactor |
US6423536B1 (en) * | 1999-08-02 | 2002-07-23 | Molecular Dynamics, Inc. | Low volume chemical and biochemical reaction system |
US6824663B1 (en) | 1999-08-27 | 2004-11-30 | Aclara Biosciences, Inc. | Efficient compound distribution in microfluidic devices |
US6623945B1 (en) * | 1999-09-16 | 2003-09-23 | Motorola, Inc. | System and method for microwave cell lysing of small samples |
AU7747600A (en) * | 1999-10-01 | 2002-05-15 | University Of California, The | Microfabricated liquid sample loading system |
WO2001032930A1 (en) | 1999-11-04 | 2001-05-10 | California Institute Of Technology | Methods and apparatuses for analyzing polynucleotide sequences |
US7329388B2 (en) | 1999-11-08 | 2008-02-12 | Princeton Biochemicals, Inc. | Electrophoresis apparatus having staggered passage configuration |
US6120184A (en) * | 1999-11-17 | 2000-09-19 | Stone Container Corporation | Bag apparatus with reclosable pour spout |
US6432290B1 (en) * | 1999-11-26 | 2002-08-13 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
US6618679B2 (en) * | 2000-01-28 | 2003-09-09 | Althea Technologies, Inc. | Methods for analysis of gene expression |
KR20020089357A (en) | 2000-02-23 | 2002-11-29 | 자이오믹스, 인코포레이티드 | Chips having elevated sample surfaces |
SE0001768D0 (en) | 2000-05-12 | 2000-05-12 | Helen Andersson | Microfluidic flow cell for manipulation of particles |
US6829753B2 (en) | 2000-06-27 | 2004-12-07 | Fluidigm Corporation | Microfluidic design automation method and system |
US20020048821A1 (en) * | 2000-08-24 | 2002-04-25 | David Storek | Sample preparing arrangement and a method relating to such an arrangement |
US7011943B2 (en) | 2000-09-06 | 2006-03-14 | Transnetyx, Inc. | Method for detecting a designated genetic sequence in murine genomic DNA |
AU2002211389A1 (en) | 2000-10-03 | 2002-04-15 | California Institute Of Technology | Microfluidic devices and methods of use |
US7097809B2 (en) | 2000-10-03 | 2006-08-29 | California Institute Of Technology | Combinatorial synthesis system |
US6782746B1 (en) * | 2000-10-24 | 2004-08-31 | Sandia National Laboratories | Mobile monolithic polymer elements for flow control in microfluidic devices |
DE60001177T2 (en) * | 2000-10-25 | 2003-10-23 | Bruker Biospin Gmbh | LC-NMR system containing a device for capturing at least one component of a chromatography flow |
CA2361980A1 (en) | 2000-11-13 | 2002-05-13 | Arkmount Systems Inc. | Heat sealing and cutting mechanism and container forming apparatus incorporating the same |
AU2002248149A1 (en) | 2000-11-16 | 2002-08-12 | Fluidigm Corporation | Microfluidic devices for introducing and dispensing fluids from microfluidic systems |
GB0028647D0 (en) | 2000-11-24 | 2001-01-10 | Nextgen Sciences Ltd | Apparatus for chemical assays |
US20020098097A1 (en) * | 2001-01-22 | 2002-07-25 | Angad Singh | Magnetically-actuated micropump |
US6852287B2 (en) * | 2001-09-12 | 2005-02-08 | Handylab, Inc. | Microfluidic devices having a reduced number of input and output connections |
US20020160518A1 (en) | 2001-04-03 | 2002-10-31 | Hayenga Jon W. | Microfluidic sedimentation |
US6752922B2 (en) * | 2001-04-06 | 2004-06-22 | Fluidigm Corporation | Microfluidic chromatography |
US6802342B2 (en) | 2001-04-06 | 2004-10-12 | Fluidigm Corporation | Microfabricated fluidic circuit elements and applications |
US7318912B2 (en) | 2001-06-07 | 2008-01-15 | Nanostream, Inc. | Microfluidic systems and methods for combining discrete fluid volumes |
JP2002370120A (en) | 2001-06-12 | 2002-12-24 | Mitsubishi Cable Ind Ltd | Cable cutting tool |
US6629820B2 (en) * | 2001-06-26 | 2003-10-07 | Micralyne Inc. | Microfluidic flow control device |
US6581441B1 (en) * | 2002-02-01 | 2003-06-24 | Perseptive Biosystems, Inc. | Capillary column chromatography process and system |
WO2003068402A1 (en) * | 2002-02-13 | 2003-08-21 | Nanostream, Inc. | Microfluidic separation column devices and fabrication methods |
US7261812B1 (en) | 2002-02-13 | 2007-08-28 | Nanostream, Inc. | Multi-column separation devices and methods |
AU2003224817B2 (en) * | 2002-04-01 | 2008-11-06 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US20040101444A1 (en) | 2002-07-15 | 2004-05-27 | Xeotron Corporation | Apparatus and method for fluid delivery to a hybridization station |
US6786708B2 (en) * | 2002-07-18 | 2004-09-07 | The Regents Of The University Of Michigan | Laminated devices and methods of making same |
US7244961B2 (en) | 2002-08-02 | 2007-07-17 | Silicon Valley Scientific | Integrated system with modular microfluidic components |
US20040197845A1 (en) | 2002-08-30 | 2004-10-07 | Arjang Hassibi | Methods and apparatus for pathogen detection, identification and/or quantification |
JP2004098757A (en) | 2002-09-05 | 2004-04-02 | Toyota Industries Corp | Air conditioner |
ATE355128T1 (en) | 2002-09-06 | 2006-03-15 | Epigem Ltd | MODULAR MICROFLUID SYSTEM |
CN101613660B (en) | 2002-12-30 | 2013-05-15 | 加州大学评议会 | Methods and apparatus for pathogen detection and analysis |
US7338637B2 (en) * | 2003-01-31 | 2008-03-04 | Hewlett-Packard Development Company, L.P. | Microfluidic device with thin-film electronic devices |
WO2004094020A2 (en) | 2003-04-17 | 2004-11-04 | Fluidigm Corporation | Crystal growth devices and systems, and methods for using same |
WO2004098757A2 (en) | 2003-05-06 | 2004-11-18 | New Jersey Institute Of Technology | Microfluidic mixing using flow pulsing |
US20050064490A1 (en) | 2003-09-23 | 2005-03-24 | University Of Missouri | Methods of synthesizing polynucleotides using thermostable enzymes |
EP2202322A1 (en) * | 2003-10-31 | 2010-06-30 | AB Advanced Genetic Analysis Corporation | Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof |
TW200536601A (en) * | 2003-11-21 | 2005-11-16 | Ebara Corp | Micorfluidic treatment method and device |
US7939249B2 (en) | 2003-12-24 | 2011-05-10 | 3M Innovative Properties Company | Methods for nucleic acid isolation and kits using a microfluidic device and concentration step |
DE602005020249D1 (en) | 2004-02-02 | 2010-05-12 | Silicon Valley Scient Inc | INTEGRATED SYSTEM WITH MODULAR MICROFLUIDIC COMPONENTS |
US8043849B2 (en) | 2004-02-24 | 2011-10-25 | Thermal Gradient | Thermal cycling device |
US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
US7077175B2 (en) | 2004-04-09 | 2006-07-18 | Hongfeng Yin | Particle packing of microdevice |
US7799553B2 (en) | 2004-06-01 | 2010-09-21 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
KR100634525B1 (en) | 2004-11-23 | 2006-10-16 | 삼성전자주식회사 | Microfluidic device comprising a microchannel disposed of a plurality of electromagnets, method for mixing a sample and method for lysis cells using the same |
US8206593B2 (en) | 2004-12-03 | 2012-06-26 | Fluidigm Corporation | Microfluidic chemical reaction circuits |
US20060163143A1 (en) * | 2005-01-26 | 2006-07-27 | Chirica Gabriela S | Microliter scale solid phase extraction devices |
CA2496481A1 (en) * | 2005-02-08 | 2006-08-09 | Mds Inc., Doing Business Through It's Mds Sciex Division | Method and apparatus for sample deposition |
US7316766B2 (en) | 2005-05-27 | 2008-01-08 | Taidoc Technology Corporation | Electrochemical biosensor strip |
AU2006299414A1 (en) | 2005-09-30 | 2007-04-12 | Caliper Life Sciences, Inc. | Microfluidic device for purifying a biological component using magnetic beads |
US20080311585A1 (en) | 2005-11-02 | 2008-12-18 | Affymetrix, Inc. | System and method for multiplex liquid handling |
US7763453B2 (en) | 2005-11-30 | 2010-07-27 | Micronics, Inc. | Microfluidic mixing and analytic apparatus |
US20080179255A1 (en) | 2007-01-29 | 2008-07-31 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Fluidic devices |
CN101004423B (en) | 2006-01-19 | 2011-12-28 | 博奥生物有限公司 | Card, kit system in use for analyzing sample of liquid |
US7749365B2 (en) * | 2006-02-01 | 2010-07-06 | IntegenX, Inc. | Optimized sample injection structures in microfluidic separations |
EP2007905B1 (en) | 2006-03-15 | 2012-08-22 | Micronics, Inc. | Integrated nucleic acid assays |
US7766033B2 (en) | 2006-03-22 | 2010-08-03 | The Regents Of The University Of California | Multiplexed latching valves for microfluidic devices and processors |
KR100785010B1 (en) | 2006-04-06 | 2007-12-11 | 삼성전자주식회사 | Method and apparatus for the purification of nucleic acids on hydrophilic surface of solid support using hydrogen bonding |
AU2007265628B2 (en) | 2006-06-23 | 2012-12-06 | Perkinelmer Health Sciences, Inc. | Methods and devices for microfluidic point-of-care immunoassays |
WO2008039875A1 (en) | 2006-09-28 | 2008-04-03 | California Institute Of Technology | System and method for interfacing with a microfluidic chip |
US20080302732A1 (en) | 2007-05-24 | 2008-12-11 | Hyongsok Soh | Integrated fluidics devices with magnetic sorting |
WO2009015296A1 (en) | 2007-07-24 | 2009-01-29 | The Regents Of The University Of California | Microfabricated dropley generator |
WO2009108260A2 (en) | 2008-01-22 | 2009-09-03 | Microchip Biotechnologies, Inc. | Universal sample preparation system and use in an integrated analysis system |
US20110137018A1 (en) | 2008-04-16 | 2011-06-09 | Cynvenio Biosystems, Inc. | Magnetic separation system with pre and post processing modules |
KR100960066B1 (en) | 2008-05-14 | 2010-05-31 | 삼성전자주식회사 | Microfluidic device containing lyophilized reagent therein and analysing method using the same |
US8323568B2 (en) | 2008-06-13 | 2012-12-04 | Honeywell International Inc. | Magnetic bead assisted sample conditioning system |
JP5311518B2 (en) | 2008-10-06 | 2013-10-09 | コーニンクレッカ フィリップス エヌ ヴェ | Microfluidic device |
WO2010077322A1 (en) | 2008-12-31 | 2010-07-08 | Microchip Biotechnologies, Inc. | Instrument with microfluidic chip |
CN102459565A (en) | 2009-06-02 | 2012-05-16 | 尹特根埃克斯有限公司 | Fluidic devices with diaphragm valves |
-
2005
- 2005-05-25 US US11/139,018 patent/US7799553B2/en active Active
- 2005-05-26 EP EP05804847A patent/EP1774042A4/en not_active Withdrawn
- 2005-05-26 WO PCT/US2005/018678 patent/WO2005118867A2/en active Application Filing
- 2005-05-26 JP JP2007515379A patent/JP2008500836A/en active Pending
- 2005-05-26 KR KR1020067026091A patent/KR101214270B1/en active IP Right Grant
-
2010
- 2010-07-27 US US12/844,544 patent/US20110020920A1/en not_active Abandoned
-
2012
- 2012-02-13 US US13/372,376 patent/US8420318B2/en active Active
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US600775A (en) * | 1898-03-15 | Punching-bag platform | ||
US3190310A (en) * | 1960-12-16 | 1965-06-22 | American Radiator & Standard | Gang valve arrangement |
US3433257A (en) * | 1966-02-01 | 1969-03-18 | Ibm | Diaphragm type fluid logic latch |
US3568692A (en) * | 1967-11-27 | 1971-03-09 | Bowles Eng Corp | Optical machining process |
US5750015A (en) * | 1990-02-28 | 1998-05-12 | Soane Biosciences | Method and device for moving molecules by the application of a plurality of electrical fields |
US5726026A (en) * | 1992-05-01 | 1998-03-10 | Trustees Of The University Of Pennsylvania | Mesoscale sample preparation device and systems for determination and processing of analytes |
US5635358A (en) * | 1992-05-01 | 1997-06-03 | Trustees Of The University Of Pennsylvania | Fluid handling methods for use in mesoscale analytical devices |
US7005292B2 (en) * | 1992-05-01 | 2006-02-28 | The Trustees Of The University Of Pennsylvania | Device and method for the detection of an analyte utilizing mesoscale flow systems |
US5639428A (en) * | 1994-07-19 | 1997-06-17 | Becton Dickinson And Company | Method and apparatus for fully automated nucleic acid amplification, nucleic acid assay and immunoassay |
US6010607A (en) * | 1994-08-01 | 2000-01-04 | Lockheed Martin Energy Research Corporation | Apparatus and method for performing microfluidic manipulations for chemical analysis and synthesis |
US5741462A (en) * | 1995-04-25 | 1998-04-21 | Irori | Remotely programmable matrices with memories |
US6197595B1 (en) * | 1995-06-29 | 2001-03-06 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US6168948B1 (en) * | 1995-06-29 | 2001-01-02 | Affymetrix, Inc. | Miniaturized genetic analysis systems and methods |
US5856174A (en) * | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US20020068357A1 (en) * | 1995-09-28 | 2002-06-06 | Mathies Richard A. | Miniaturized integrated nucleic acid processing and analysis device and method |
US5705813A (en) * | 1995-11-01 | 1998-01-06 | Hewlett-Packard Company | Integrated planar liquid handling system for maldi-TOF MS |
US5908552A (en) * | 1995-12-14 | 1999-06-01 | Hewlett-Packard Company | Column for capillary chromatographic separations |
US5863502A (en) * | 1996-01-24 | 1999-01-26 | Sarnoff Corporation | Parallel reaction cassette and associated devices |
US6238538B1 (en) * | 1996-04-16 | 2001-05-29 | Caliper Technologies, Corp. | Controlled fluid transport in microfabricated polymeric substrates |
US6074827A (en) * | 1996-07-30 | 2000-06-13 | Aclara Biosciences, Inc. | Microfluidic method for nucleic acid purification and processing |
US5770029A (en) * | 1996-07-30 | 1998-06-23 | Soane Biosciences | Integrated electrophoretic microdevices |
US6056860A (en) * | 1996-09-18 | 2000-05-02 | Aclara Biosciences, Inc. | Surface modified electrophoretic chambers |
US6379929B1 (en) * | 1996-11-20 | 2002-04-30 | The Regents Of The University Of Michigan | Chip-based isothermal amplification devices and methods |
US6537757B1 (en) * | 1997-03-05 | 2003-03-25 | The Regents Of The University Of Michigan | Nucleic acid sequencing and mapping |
US6348318B1 (en) * | 1997-04-04 | 2002-02-19 | Biosite Diagnostics | Methods for concentrating ligands using magnetic particles |
US6235471B1 (en) * | 1997-04-04 | 2001-05-22 | Caliper Technologies Corp. | Closed-loop biochemical analyzers |
US5885470A (en) * | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
US20020051992A1 (en) * | 1997-05-23 | 2002-05-02 | Lynx Therapeutics, Inc. | System and apparatus for sequential processing of analytes |
US5900130A (en) * | 1997-06-18 | 1999-05-04 | Alcara Biosciences, Inc. | Method for sample injection in microchannel device |
US6073482A (en) * | 1997-07-21 | 2000-06-13 | Ysi Incorporated | Fluid flow module |
US6190616B1 (en) * | 1997-09-11 | 2001-02-20 | Molecular Dynamics, Inc. | Capillary valve, connector, and router |
US6551839B2 (en) * | 1997-09-11 | 2003-04-22 | Amersham Biosciences Corp. | Method of merging chemical reactants in capillary tubes |
US6027031A (en) * | 1997-12-19 | 2000-02-22 | Carrier Corporation | Method and apparatus for changing operational modes of a transport refrigeration system |
US6179962B1 (en) * | 1997-12-31 | 2001-01-30 | Hercules Incorporated | Paper having improved strength characteristics and process for making same |
US6251343B1 (en) * | 1998-02-24 | 2001-06-26 | Caliper Technologies Corp. | Microfluidic devices and systems incorporating cover layers |
US20020025576A1 (en) * | 1998-03-17 | 2002-02-28 | Cepheid | Integrated sample analysis device |
US6544734B1 (en) * | 1998-10-09 | 2003-04-08 | Cynthia G. Briscoe | Multilayered microfluidic DNA analysis system and method |
US20030021734A1 (en) * | 1999-02-16 | 2003-01-30 | Vann Charles S. | Bead dispensing system |
US20090137413A1 (en) * | 1999-02-23 | 2009-05-28 | Caliper Life Sciences, Inc. | Manipulation of Microparticles In Microfluidic Systems |
US20020048536A1 (en) * | 1999-03-03 | 2002-04-25 | Bergh H. Sam | Parallel flow process optimization reactors |
US6048100A (en) * | 1999-03-10 | 2000-04-11 | Industrial Label Corp. | Resealable closure for a bag |
US6899137B2 (en) * | 1999-06-28 | 2005-05-31 | California Institute Of Technology | Microfabricated elastomeric valve and pump systems |
US20020025529A1 (en) * | 1999-06-28 | 2002-02-28 | Stephen Quake | Methods and apparatus for analyzing polynucleotide sequences |
US6533914B1 (en) * | 1999-07-08 | 2003-03-18 | Shaorong Liu | Microfabricated injector and capillary array assembly for high-resolution and high throughput separation |
US7015030B1 (en) * | 1999-07-28 | 2006-03-21 | Genset S.A. | Microfluidic devices and uses thereof in biochemical processes |
US6524456B1 (en) * | 1999-08-12 | 2003-02-25 | Ut-Battelle, Llc | Microfluidic devices for the controlled manipulation of small volumes |
US6705345B1 (en) * | 1999-11-08 | 2004-03-16 | The Trustees Of Boston University | Micro valve arrays for fluid flow control |
US20110048945A1 (en) * | 1999-11-26 | 2011-03-03 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
US20040053290A1 (en) * | 2000-01-11 | 2004-03-18 | Terbrueggen Robert Henry | Devices and methods for biochip multiplexing |
US20020022587A1 (en) * | 2000-03-28 | 2002-02-21 | Ferguson Alastair V. | Methods for effecting neuroprotection |
US6885982B2 (en) * | 2000-06-27 | 2005-04-26 | Fluidigm Corporation | Object oriented microfluidic design method and system |
US20020047003A1 (en) * | 2000-06-28 | 2002-04-25 | William Bedingham | Enhanced sample processing devices, systems and methods |
US20030070677A1 (en) * | 2000-07-24 | 2003-04-17 | The Regents Of The University Of Michigan | Compositions and methods for liquid metering in microchannels |
US20020058332A1 (en) * | 2000-09-15 | 2002-05-16 | California Institute Of Technology | Microfabricated crossflow devices and methods |
US6521188B1 (en) * | 2000-11-22 | 2003-02-18 | Industrial Technology Research Institute | Microfluidic actuator |
US20090004494A1 (en) * | 2000-12-29 | 2009-01-01 | Kimberly-Clark Worldwide, Inc. | Laminated absorbent product with increased strength in defined areas |
US20040037739A1 (en) * | 2001-03-09 | 2004-02-26 | Mcneely Michael | Method and system for microfluidic interfacing to arrays |
US6853287B1 (en) * | 2001-03-30 | 2005-02-08 | Intel Corporation | Coil for use on a substrate |
US20030008308A1 (en) * | 2001-04-06 | 2003-01-09 | California Institute Of Technology | Nucleic acid amplification utilizing microfluidic devices |
US7005493B2 (en) * | 2001-04-06 | 2006-02-28 | Fluidigm Corporation | Polymer surface modification |
USD488818S1 (en) * | 2001-06-27 | 2004-04-20 | Fluidigm Corporation | Fluidic rotary mixer square icon for a display screen |
USD486156S1 (en) * | 2001-06-27 | 2004-02-03 | Fluidigm Corporation | Fluidic taper icon for a display screen |
US20070105163A1 (en) * | 2001-08-31 | 2007-05-10 | Grate Jay W | Flow-controlled magnetic particle manipulation |
US6532997B1 (en) * | 2001-12-28 | 2003-03-18 | 3M Innovative Properties Company | Sample processing device with integral electrophoresis channels |
US6685442B2 (en) * | 2002-02-20 | 2004-02-03 | Sandia National Laboratories | Actuator device utilizing a conductive polymer gel |
US20040014091A1 (en) * | 2002-03-11 | 2004-01-22 | Athenix Corporation | Integrated system for high throughput capture of genetic diversity |
US20040072278A1 (en) * | 2002-04-01 | 2004-04-15 | Fluidigm Corporation | Microfluidic particle-analysis systems |
US20060027456A1 (en) * | 2002-05-24 | 2006-02-09 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
US20090084679A1 (en) * | 2002-05-24 | 2009-04-02 | The Governors Of The University Of Alberta | Apparatus and method for trapping bead based reagents within microfluidic analysis systems |
US7198759B2 (en) * | 2002-07-26 | 2007-04-03 | Applera Corporation | Microfluidic devices, methods, and systems |
US6870185B2 (en) * | 2002-08-02 | 2005-03-22 | Amersham Biosciences (Sv) Corp | Integrated microchip design |
US20040038385A1 (en) * | 2002-08-26 | 2004-02-26 | Langlois Richard G. | System for autonomous monitoring of bioagents |
US20040063217A1 (en) * | 2002-09-27 | 2004-04-01 | Webster James Russell | Miniaturized fluid delivery and analysis system |
US20050053952A1 (en) * | 2002-10-02 | 2005-03-10 | California Institute Of Technology | Microfluidic nucleic acid analysis |
US20040086872A1 (en) * | 2002-10-31 | 2004-05-06 | Childers Winthrop D. | Microfluidic system for analysis of nucleic acids |
US20080047836A1 (en) * | 2002-12-05 | 2008-02-28 | David Strand | Configurable Microfluidic Substrate Assembly |
US20090060797A1 (en) * | 2002-12-30 | 2009-03-05 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
US20060073484A1 (en) * | 2002-12-30 | 2006-04-06 | Mathies Richard A | Methods and apparatus for pathogen detection and analysis |
US7323305B2 (en) * | 2003-01-29 | 2008-01-29 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
US7046357B2 (en) * | 2003-01-30 | 2006-05-16 | Ciphergen Biosystems, Inc. | Apparatus for microfluidic processing and reading of biochip arrays |
US7488603B2 (en) * | 2003-07-14 | 2009-02-10 | Phynexus, Inc. | Method and device for extracting an analyte |
US20050047967A1 (en) * | 2003-09-03 | 2005-03-03 | Industrial Technology Research Institute | Microfluidic component providing multi-directional fluid movement |
US20110076735A1 (en) * | 2004-09-15 | 2011-03-31 | Jovanovich Stevan B | Microfluidic Devices |
US20100068723A1 (en) * | 2004-09-15 | 2010-03-18 | Stevan Bogdan Jovanovich | Microfluidic devices |
US20060057209A1 (en) * | 2004-09-16 | 2006-03-16 | Predicant Biosciences, Inc. | Methods, compositions and devices, including microfluidic devices, comprising coated hydrophobic surfaces |
US20090056822A1 (en) * | 2004-10-13 | 2009-03-05 | Kionix, Inc. | Microfluidic Pump and Valve Structures and Fabrication Methods |
US20060076068A1 (en) * | 2004-10-13 | 2006-04-13 | Kionix Corporation | Microfluidic pump and valve structures and fabrication methods |
US20070017812A1 (en) * | 2005-03-30 | 2007-01-25 | Luc Bousse | Optimized Sample Injection Structures in Microfluidic Separations |
US20070034025A1 (en) * | 2005-08-09 | 2007-02-15 | Cfd Research Corporation | Electrostatic sampler and method |
US20070122819A1 (en) * | 2005-11-25 | 2007-05-31 | Industrial Technology Research Institute | Analyte assay structure in microfluidic chip for quantitative analysis and method for using the same |
US20080014576A1 (en) * | 2006-02-03 | 2008-01-17 | Microchip Biotechnologies, Inc. | Microfluidic devices |
US20080014589A1 (en) * | 2006-05-11 | 2008-01-17 | Link Darren R | Microfluidic devices and methods of use thereof |
US20080124723A1 (en) * | 2006-06-30 | 2008-05-29 | Canon U.S. Life Sciences, Inc. | Combined thermal devices for thermal cycling |
US20090035770A1 (en) * | 2006-10-25 | 2009-02-05 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
US20110039303A1 (en) * | 2007-02-05 | 2011-02-17 | Stevan Bogdan Jovanovich | Microfluidic and nanofluidic devices, systems, and applications |
US20110027913A1 (en) * | 2007-02-06 | 2011-02-03 | Bau Haim H | Multiplexed nanoscale electrochemical sensors for multi-analyte detection |
US20090134069A1 (en) * | 2007-07-13 | 2009-05-28 | Handylab, Inc. | Integrated Heater and Magnetic Separator |
US20090053799A1 (en) * | 2007-08-23 | 2009-02-26 | Cynvenio Biosystems, Llc | Trapping magnetic sorting system for target species |
US20110005932A1 (en) * | 2009-06-05 | 2011-01-13 | Integenx Inc. | Universal sample preparation system and use in an integrated analysis system |
Cited By (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090060797A1 (en) * | 2002-12-30 | 2009-03-05 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
US9644623B2 (en) | 2002-12-30 | 2017-05-09 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
US9651039B2 (en) | 2002-12-30 | 2017-05-16 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
US20100224255A1 (en) * | 2002-12-30 | 2010-09-09 | The Regents Of The University Of California | Fluid control structures in microfluidic devices |
US8420318B2 (en) | 2004-06-01 | 2013-04-16 | The Regents Of The University Of California | Microfabricated integrated DNA analysis system |
US9752185B2 (en) | 2004-09-15 | 2017-09-05 | Integenx Inc. | Microfluidic devices |
US8551714B2 (en) | 2004-09-15 | 2013-10-08 | Integenx Inc. | Microfluidic devices |
US8476063B2 (en) | 2004-09-15 | 2013-07-02 | Integenx Inc. | Microfluidic devices |
US20100068723A1 (en) * | 2004-09-15 | 2010-03-18 | Stevan Bogdan Jovanovich | Microfluidic devices |
US20110076735A1 (en) * | 2004-09-15 | 2011-03-31 | Jovanovich Stevan B | Microfluidic Devices |
US8431390B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Systems of sample processing having a macro-micro interface |
US8431340B2 (en) | 2004-09-15 | 2013-04-30 | Integenx Inc. | Methods for processing and analyzing nucleic acid samples |
US8286665B2 (en) | 2006-03-22 | 2012-10-16 | The Regents Of The University Of California | Multiplexed latching valves for microfluidic devices and processors |
US8841116B2 (en) | 2006-10-25 | 2014-09-23 | The Regents Of The University Of California | Inline-injection microdevice and microfabricated integrated DNA analysis system using same |
US20110039303A1 (en) * | 2007-02-05 | 2011-02-17 | Stevan Bogdan Jovanovich | Microfluidic and nanofluidic devices, systems, and applications |
US8557518B2 (en) | 2007-02-05 | 2013-10-15 | Integenx Inc. | Microfluidic and nanofluidic devices, systems, and applications |
US20100285975A1 (en) * | 2007-07-24 | 2010-11-11 | The Regents Of The University Of California | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions |
US8454906B2 (en) | 2007-07-24 | 2013-06-04 | The Regents Of The University Of California | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions |
US8748165B2 (en) | 2008-01-22 | 2014-06-10 | Integenx Inc. | Methods for generating short tandem repeat (STR) profiles |
US20090253181A1 (en) * | 2008-01-22 | 2009-10-08 | Microchip Biotechnologies, Inc. | Universal sample preparation system and use in an integrated analysis system |
US8672532B2 (en) | 2008-12-31 | 2014-03-18 | Integenx Inc. | Microfluidic methods |
US20100165784A1 (en) * | 2008-12-31 | 2010-07-01 | Microchip Biotechnologies, Inc., A California Corporation | Instrument with microfluidic chip |
US20100303687A1 (en) * | 2009-06-02 | 2010-12-02 | Integenx Inc. | Fluidic devices with diaphragm valves |
US8388908B2 (en) | 2009-06-02 | 2013-03-05 | Integenx Inc. | Fluidic devices with diaphragm valves |
US20110223605A1 (en) * | 2009-06-04 | 2011-09-15 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for DNA analysis |
US20110229897A1 (en) * | 2009-06-04 | 2011-09-22 | Lockheed Martin Corporation | Optical approach for microfluidic DNA electrophoresis detection |
US9656261B2 (en) | 2009-06-04 | 2017-05-23 | Leidos Innovations Technology, Inc. | DNA analyzer |
US9649631B2 (en) | 2009-06-04 | 2017-05-16 | Leidos Innovations Technology, Inc. | Multiple-sample microfluidic chip for DNA analysis |
US9067207B2 (en) | 2009-06-04 | 2015-06-30 | University Of Virginia Patent Foundation | Optical approach for microfluidic DNA electrophoresis detection |
US20110126911A1 (en) * | 2009-12-01 | 2011-06-02 | IntegenX Inc., a California Corporation | Composite Plastic Articles |
US8584703B2 (en) | 2009-12-01 | 2013-11-19 | Integenx Inc. | Device with diaphragm valve |
US8512538B2 (en) | 2010-05-28 | 2013-08-20 | Integenx Inc. | Capillary electrophoresis device |
US9121058B2 (en) | 2010-08-20 | 2015-09-01 | Integenx Inc. | Linear valve arrays |
US8763642B2 (en) | 2010-08-20 | 2014-07-01 | Integenx Inc. | Microfluidic devices with mechanically-sealed diaphragm valves |
US9731266B2 (en) | 2010-08-20 | 2017-08-15 | Integenx Inc. | Linear valve arrays |
US8961764B2 (en) | 2010-10-15 | 2015-02-24 | Lockheed Martin Corporation | Micro fluidic optic design |
US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
US9988676B2 (en) | 2012-02-22 | 2018-06-05 | Leidos Innovations Technology, Inc. | Microfluidic cartridge |
Also Published As
Publication number | Publication date |
---|---|
EP1774042A2 (en) | 2007-04-18 |
US20050287572A1 (en) | 2005-12-29 |
JP2008500836A (en) | 2008-01-17 |
US8420318B2 (en) | 2013-04-16 |
US7799553B2 (en) | 2010-09-21 |
WO2005118867A2 (en) | 2005-12-15 |
US20120142010A1 (en) | 2012-06-07 |
KR101214270B1 (en) | 2012-12-20 |
EP1774042A4 (en) | 2010-09-29 |
KR20070030827A (en) | 2007-03-16 |
WO2005118867A3 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8420318B2 (en) | Microfabricated integrated DNA analysis system | |
US11162137B2 (en) | Apparatus, system, and method using immiscible-fluid-discrete-volumes | |
AU2016250009B2 (en) | Multiplexed, continuous-flow, droplet-based platform for high-throughput genetic detection | |
US9731266B2 (en) | Linear valve arrays | |
US8454906B2 (en) | Microfabricated droplet generator for single molecule/cell genetic analysis in engineered monodispersed emulsions | |
US8841116B2 (en) | Inline-injection microdevice and microfabricated integrated DNA analysis system using same | |
US5716825A (en) | Integrated nucleic acid analysis system for MALDI-TOF MS | |
US20050142565A1 (en) | Nucleic acid purification chip | |
EP1418243A2 (en) | Microfluidic system for analyzing nucleic acids | |
JP2012189615A (en) | Microfluid device | |
JP2001521622A (en) | Closed-loop biochemical analyzer | |
CA2372112A1 (en) | Inefficient fast pcr | |
EP2732053B1 (en) | Systems, apparatus and methods for biochemical analysis | |
EP2231851A2 (en) | System for the detection of a biological pathogen and use thereof | |
Matsubara et al. | Application of a microchamber array for DNA amplification using a novel dispensing method | |
CA2473308C (en) | Assay and kit for analyzing gene expression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, CALIF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MATHIES, RICHARD A.;BLAZEJ, ROBERT;LIU, CHUNG;AND OTHERS;SIGNING DATES FROM 20050721 TO 20050723;REEL/FRAME:024749/0298 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: NIH, MARYLAND Free format text: CONFIRMATORY LICENSE;ASSIGNOR:UNIVERSITY OF CALIFORNIA;REEL/FRAME:043804/0218 Effective date: 20171006 |